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ABSTRACT 
Objective: The aims of this thesis were to evaluate if there is an association between 
diverticular disease and colorectal cancer (Paper I), to assess any genetic contribution to 
the occurrence of diverticular disease (Paper II), determine how common hospitalization 
and surgery for diverticular disease are in measures of admission rates, incidence rates and 
lifetime risk (Paper II), and to estimate mortality in diverticulitis patients, needing hospital 
care (Paper IV). 
Methods: Swedish national registries were cross-linked through individual personal 
identification numbers. Data on admissions for diverticular disease and diverticulitis were 
retrieved from the National Patient Register. In Paper I, 41,037 colon cancer cases, 
registered in the Swedish Cancer Registry, were compared to matched colon cancer-free 
controls in concern of preceding admission for diverticular disease. In Paper II, including 
104,452 twins in the Swedish Twin Registry, diverticular disease admissions were 
compared between monozygotic and dizygotic twins. Admission rates, incidence rates and 
lifetime risk for hospital admission for diverticular disease and diverticular disease surgery 
were analyzed in 95,049 individuals with diverticular disease admissions in Paper III, by 
using data from the Total Population Register in estimating risk sets. Survival analyses 
were used when comparing mortality in 83,461 patients with a first admission for 
diverticulitis with matched disease-free individuals, in Paper IV. 
Results: Within the first 6 months after admission due to diverticular disease, odds ratios 
of having a colon cancer were up to 31.49 (95% CI 19.00-52.21). After the first year, there 
was no association between diverticular disease and colon cancer (Paper I). Odds ratio for 
diverticular disease admission given that the co-twin was affected/not affected, was higher 
in monozygotic twins compared to same-sex dizygotic twins (7.15 [95% CI 4.82-10.61] vs. 
3.20 [95% CI 2.21-4.63]). Heritability was estimated to 40% (Paper II). Incidence rates for 
diverticular disease admission were 47.4 (95% CI 47.1-47.4) and for diverticular disease 
surgery 8.4 (95% CI 8.2-8.5) per 100,000 person-years. Corresponding admission rates 
were 70.8 (95% CI 70.4-71.2) and 8.7 (95% CI 8.6-9.9). Following an increase 1990-1994, 
rates remained rather constant thereafter. The estimated remaining lifetime risk for 
diverticular disease admission at the age of 30 was 3.1% in men and 5.0% in women (Paper 
III). Diverticulitis patients had a four times higher mortality compared to disease-free 
individuals in short term; the first 100 days after initial admission, Hazard Ratio (HR) 4.44 
(95% CI 4.26-4.63). Within this time, 11.4% of patients receiving surgical treatment died. 
Among all diverticulitis patients, long term mortality, from day 101 to five years, was 
increased 11% (HR 1.11, 95% CI 1.09-1.13). 
Conclusions: Hospitalization for diverticular disease is not associated with colon cancer 
after one year. The first 12 months after initial hospitalization is however highly associated 
with colon cancer. Therefore, colon cancer should be excluded after a first episode of 
suspected diverticulitis, due to the risk of misdiagnosing colon cancer as diverticulitis. 
Genetic influence is of importance in diverticular disease occurrence. The continuous 
increase of diverticular disease hospitalizations found in other studies are not present in 
Sweden. Diverticulitis patients have a significantly reduced survival compared to disease-
free individuals, both in short- and long term. 
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1 BACKGROUND 
1.1 HISTORY 
Diverticula of the colon have been recognized for the last 300 years. In 1700, a French 
surgeon named Alexis Littre described a diverticulum at a post mortem examination (1). 
The herniation of colonic mucosa through the rest of the colonic wall was further described 
by three pathologists: Matthew Baillie, who was Kings George IIIs and Georges IVs 
physician, authored in 1793 The Morbid Anatomy of Some of the Most Important Parts of 
the Human Body, which is considered the first systematic study of pathology (2, 3); Jean 
Cruveilhier, most known for his contribution in describing the nervous system and 
particulary multiple sclerosis, wrote in his monumental book Traité d’anatomie 
pathologique, in 1849:  
We not infrequently find between the bands of longitudinal muscle fibers in 
the sigmoid a series of small, dark, pear-shaped tumours, which are formed 
by herniae of the mucous membrane through the gaps in the muscle coat (4). 
Rudolf Virchow, famous also for being the first describing leukemia, embolism and 
thrombosis, described the inflamed diverticula as “chronic adhesive peritonitis” in 1854 
(5). 
Having been so far a curiosity among pathologists, Graser was the first to write a paper 
that caught the medical communities’ interest. In 1899, he pointed out that diverticula 
were far from uncommon and that they could become life-threatening if inflamed (6).  In 
the beginning of the 20th century, x-ray machines were rapidly getting popular and Carman 
was the first in 1915 to show diverticula with this new imaging technique (7). At this time, 
complications of diverticula such as perforation, abscess formation and fistula were known 
(8) but since colonic resection carried a 10 % mortality, treatment was kept conservative 
as long as possible (9). As advances in anesthesia, development of antibiotics and better 
supportive therapy followed, mortality of colon resection dropped to an acceptable level 
(9).  
In the 1960’s and 1970’s, Neil S Painter argued that it was a deficiency disease of dietary 
fiber, after having compared the incidence in Western countries, where we eat less fiber, 
to the one in rural Africa and having estimated intra-luminal pressure in the colon. Diet of 
less fiber alters the role of segmentation of the colon, which has a function of transporting 
faeces. Stagnating faeces would cause higher intraluminal pressure and development of 
diverticula (10). This way of describing the pathogenesis has been established for the last 
decades but has been questioned the last few years. 
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1.2 ANATOMY AND PHYSIOLOGY OF THE COLON 
The colon, with its length of 1-1.5 meters, is the longest part of the large intestine, which 
also involves caecum, appendix vermiformis, rectum and the anal canal. Its main functions 
are propulsion, storage and to absorb water and electrolytes. Sodium is actively 
transported from lumen to blood, with the accompanying osmotic absorption of water. 
There is normally also a net movement of potassium from blood into the lumen. As food 
enters from the caecum, most breakdown is already finished but some digestion is made 
from the many bacteria living there. By them, undigested polysaccharides (fiber) are 
metabolized to short-chain fatty acids, which are then absorbed (11). In this process flatus 
(gas) is formed. The colon secretes bicarbonate that neutralizes the short-chain fatty 
acids, and in this way stabilizing pH in lumen. The bacteria also produce small amounts of 
vitamin K that can be absorbed (11). About 1500 ml content enters the large intestine 
each day and it stays there for 12-24 hours. Most is absorbed and less than 200 grams 
remains in the stool. 
As most walls of the entire gastrointestinal tract, the colon wall consists of four layers: 1) 
the innermost mucosa, comprising of an epithelium, lamina propria, and muscularis 
mucosae, 2) the submucosa, 3) the muscularis externa, consisting of inner circular and 
outer longitudinal layers and 4) the serosa (12). The internal surface of the colon is lined 
by simple columnar epithelium including goblets cells that secrete large amounts of 
lubricating mucus, and absorptive cells that resorbs water and electrolytes. Stem cells at 
the bases of the intestinal crypts replace the epithelial cells every week (12). Compared to 
the rest of the gastrointestinal tract, the lamina propria in the colon contains more 
lymphoid tissue, reflecting the extensive bacterial flora here (12). The teniae coli are 
thickenings of the longitudinal layer of the muscularis externa, formed as three longitudinal 
stripes spaced at intervals of the colon. Tension in these muscles cause the colon to 
pucker into sack-like haustra (12). Colon motility has been described as three different 
types of contractions; 1) rhythmic phasic contractions (RPC) in the circular smooth 
muscle, which occurs two times per hour, in order to mix food and propels the content 
slowly forward, 2) giant migration contractions (GMC) occurring three to four times a day, 
generally following a meal, in where a wave of intense contractions causes mass movement 
forward and 3) tonic contractions which aid RPC in its function (11, 13) 
The proximal colon is supplied by the superior mesenteric vessels while the distal part is 
supplied by the inferior mesenteric vessels. Small branches, vasa recta, penetrate the 
circular muscle layer and continue in the submucosa. Arteries, veins and lymphatic vessels 
follow each other into the colon.  
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The innervation of the gastrointestinal tract is complex. The speed at which the colon 
operates is set by the balance between the sympathetic innervation (via superior 
mesenteric and celiac ganglia plexuses in proximal colon, and inferior mesenteric and 
hypogastric plexuses in distal colon, respectively) and the parasympathetic innervation (via 
the vagus nerve in proximal colon and pelvic splanchnic nerves in distal colon, 
respectively).  
Within the colon wall, as well as the rest of the gastrointestinal tract, a large number of 
nerve cell bodies and nerve fibers constitute the enteric nervous system, divided into the 
myenteric nerve plexus between the circular and longitudinal muscle layers and 
submucosal nerve plexus within mucosa. The enteric nervous is connected to the central 
nervous system through both parasympathetic and sympathetic nerves (12). 
1.3 DEFINITION AND CLASSIFICATION 
Diverticulosis of the colon is defined as presence of diverticula, protrusions of mucosa 
through the muscular layers of the bowel wall (14), usually considered asymptomatic. 
Diverticulitis is defined as inflammation in and around diverticula. There is no international 
agreement on diverticular disease definition or classification (272) but the term diverticular 
disease is mostly used expressing a symptomatic state, excluding it from diverticulosis. 
Although, in some literature, especially American, diverticular disease is used as a general 
term for both diverticulosis and diverticulitis (14).  
Several different classifications have been used describing the different variations with 
focus on clinical symptoms, imaging findings or operative findings. There is still no 
internationally used classification that covers all variations which has led to conflicting 
terminology in literature (15). The most important classifications are described below. 
In this text, the term diverticular disease is used as a general term including all states of 
the disease, also asymptomatic diverticulosis. When excluding asymptomatic diverticulosis 
this will be declared. 
Hinchey's classification (16) from 1978 was intended to stratify surgical procedures in the 
presence of perforated diverticulitis and is still used (Table 1). When computed 
tomography became more widely used, with ability to provide more information, Sher et al. 
modified the Hinchey's classification to distinguish between a pericolic abscess (stage 1), 
distant abscesses that might be possible to treat with percutaneous drainage (stage IIa), 
and complex abscesses associated with a possible fistula (stage IIb) (15, 17) (Table 1). 
Wasvary et al. published another modification of Hincheys classification in 1999. In this 
modification clinical mild disease was included (stage 0) and a difference was made between 
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confined pericolic inflammation or phlegmon (stage Ia) and a confined pericolic abscess 
(stage Ib) (15, 18) (Table 1). Kaiser defined later specific CT findings for this classification 
(15, 19) (Table1). 
Table 1. Hinchey classifications and Kaiser radiological classification (16-19) 
Hinchey classification 
 
Modified Hinchey 
classification by Sher 
Modified Hinchey 
classification by 
Wasvary 
CT findings by Kaiser 
    0 Mild clinical 
diverticulitis Diverticula ± colonic wall thickening 
I Pericolic abscess 
or phlegmon 
I  Pericolic abscess Ia Confined pericolic 
inflammation or 
phlegmon 
Colonic wall 
thickening with 
pericolic soft tissue 
changes 
Ib Pericolic or 
mesocolic abscess 
Ia changes + 
pericolic or 
mesocolic abscess 
II Pelvic, 
intraabdominal, or 
retroperitoneal 
abscess 
IIa 
 
Distant abscess 
amenable to 
percutaneous 
drainage 
II Pelvic, distant 
intraabdominal, or 
retroperitoneal 
abscess 
Ia changes + distant 
abscess (generally 
deep in the pelvis or 
interloop regions) 
IIb Compex abscess 
associated with 
fistula 
III  Generalized 
purulent peritonitis 
III Generalized 
purulent 
peritonitis 
III Generalized 
purulent peritonitis 
Free gas associated 
with localized or 
generalized ascites 
and possible 
peritoneal wall 
thickening 
IV Generalized fecal 
peritonitis 
IV Fecal peritonitis IV Generalized fecal 
peritonitis 
Same findings as III 
The European Association of Endoscopic Surgeons published a classification consensus 
statement in 1999, differentiating symptomatic uncomplicated disease, recurrent 
symptomatic disease and complicated disease with sub-classifications (Appendix Table A1) 
(15, 20). 
In Germany, the most popular classification has been the one published by Hansen/Stock 
in 1998 (Appendix Table A2) (15, 21). It has been considered useful in clinical practice but 
has not won acceptance internationally (15). Another German classification is the one 
published by Siewert et al in 1995 which is similar in differentiating aspects of acute 
complicated diverticulitis (15, 22) (Appendix Table A2).  
Neff et al suggested about the same time a simple classification that has been used widely 
(23). This classification has been modified too, adding a substage —Ia— localized pericolic 
pneumoperitoneum without abscess (24) (Table 2). Tursi et al introduced a simple clinical 
classification of uncomplicated and complicated diverticulitis in 2008, based on findings as 
inflammatory markers in blood, and imaging (25). 
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Table 2. Modified Neff Classification (24) 
Stage Findings  
0 
 
Uncomplicated diverticulitis. Diverticula, thickening of the wall, increased density of the 
pericolic fat . 
I Locally complicated diverticulitis 
a Localized pneumoperitoneum in the form of air bubbles 
b Abscess (< 4 cm) 
II Complicated diverticulitis with pelvic abscess. Abscess > 4 cm in pelvis 
III 
 
Complicated diverticulitis with distant abscess. Abscess in abdominal cavity (outside 
pelvis) 
IV 
 
Complicated diverticulitis with other distant complications. Abundant 
pneumoperitoneum and/or intra‐abdominal free liquid 
Another classification that is strictly based on CT-scan findings is the one from 
Ambrosetti, which is often used internationally (Table 3) (26). 
Table 3. Ambrosetti classification (26) 
Moderate diverticulitis  Localized sigmoid wall thickening (³5 mm) 
 Pericolic fat stranding 
Severe diverticulitis Abscess 
 Extraluminal air 
 Extraluminal contrast 
In an attempt to combine the classifications above and also include post-inflammatory 
changes like fistulas or stenosis, Klarenbeek et al, from the Netherlands, published a 
sophisticated classification in 2012 differentiating between a) uncomplicated, b) chronic 
complicated and c) acute complicated disease. For each classification, clinical findings, 
radiological findings and treatment modalities are presented (Appendix Table A3) (15). 
Since then, new German guidelines, accepted by the German Societies of Gastroenterology 
and of Visceral Surgery have been published, named Classification of Diverticular Disease 
(CDD). In this classification, one is not tied to a specific diagnostic preference and the 
definitions are not stated as severity stages, but as different types of the disease (27, 28) 
(Table 4). Gastrointestinal bleeding is included as well as the rather new term symptomatic 
uncomplicated diverticular disease (SUDD). Asymptomatic diverticulosis is included (type 
0), but not stated as a disease. 
Table 4. Classification of Diverticular Disease (CDD) (28) 
Type Definition Symptoms  
0 Asymptomatic diverticulosis Random finding; asymptomatic; not a disease per se  
1 Acute uncomplicated 
diverticulitis  
 
1a Diverticulitis without 
peridiverticulitis  
 
Symptoms attributable to diverticula; signs of 
inflammation (laboratory tests): optional; typical cross-
sectional imaging  
1b Diverticulitis with phlegmonous 
peridiverticulitis  
Signs of inflammation (laboratory tests): mandatory; 
cross-sectional imaging: phlegmonous diverticulitis  
2 Acute complicated diverticulitis  Signs of inflammation (laboratory tests): mandatory; 
typical cross-sectional imaging  
2a Microabscess  Concealed perforation, small abscess (≤1 cm); minimal 
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Type Definition Symptoms  
paracolic air  
2b Macroabscess  Paracolic or mesocolic abscess (>1 cm)  
2c Free perforation  Free perforation, free air/fluid; generalized peritonitis  
2ci Purulent peritonitis   
2cii Fecal peritonitis   
3 Chronic diverticular disease Relapsing or persistent symptomatic diverticular disease  
3a Symptomatic uncomplicated 
diverticular disease (SUDD)  Localized symptoms; laboratory test (calprotectin): optional  
3b Relapsing diverticulitis without 
complications  
Signs of inflammation (laboratory tests): present; cross-
sectional imaging: indicates inflammation  
3c Relapsing diverticulitis with 
complications  
Identification of stenoses, fistulas, conglomerate tumor  
4 Diverticular bleeding  Diverticula identified as the source of bleeding  
Advances in imaging techniques and changes in treatment, as well as different focuses for 
surgeons, gastroenterologists and radiologists, have steadily demanded modified 
classifications but is a problem when comparing studies and making guidelines. 
1.4 EPIDEMIOLOGY 
1.4.1 Incidence and prevalence 
Many patients with diverticulosis will never have any disease-related symptoms why 
incidence and prevalence studies are difficult. It has been showed in United States that 
about 30% of individuals aged 50-59 years and 70% of those aged ≥80 years at colonoscopy 
or sigmoidoscopy are diagnosed with the condition (29). These findings should not have 
been influenced by symptoms or other indications for the procedure according to the 
authors and could therefore be considered prevalence in the American population. 
Comparably, in a population-based study from Sweden, where participants underwent 
colonoscopy, the prevalence of diverticulosis in the age group 60-69 years was >30% and 
similarly increasing with age (30). It was also shown that the prevalence of diverticulosis in 
women and men are similar, which is in accordance to other studies (30, 31). The 
incidence has been estimated to 634/100,000 person-years in a retrospective study 
including 2,222 patients having for various reasons undergone colonoscopy (32). 
Regarding incidence of symptomatic diverticular disease, including diverticulitis, reports 
are scarce. Since symptomatic diverticular disease has a variety of symptoms, some 
patients do not seek health care, others visit their general practitioner and others need 
emergency care. This makes it difficult to study incidence, also because patient visits often 
are registered in different health registries depending on level of care. In the literature, 
focus is usually on diverticular disease demanding hospital inpatient care, probably 
because most register-data are available in this group of patients. Most recent studies 
have reported admission rates rather than incidence rates, which are not exactly the same 
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since a patient can have a recurrent disease with several readmissions. Also, primary data 
sources are usually not covering the whole population. See Table 5 for studies on 
admission rates and incidence rates, including our own (paper III). Incidence rate has 
reported to be 16-188/100.000 person-years and is increasing with age. There is a female 
predominance (sex ratio commonly reported to 1.5:1) which is more pronounced with 
increasing age (33, 34). In the last decades, incidence seem to be rising in the Western 
world, especially in younger age groups (33, 35, 36). In African and Asian countries, 
diverticular disease has traditionally been rare but seems to have become more common 
when influenced by westernized culture last decades (37). As in studies of admission rates, 
studies of incidence rates have not covered the whole nation-wide population and 
generalizability can therefore be problematic.  
Another way of describing the impact of a disorder is to estimate the risk of developing the 
disease during the remaining lifespan. This is a quantity that is usually easier to 
communicate to patients in clinical practice. This has been done on several other diseases, 
but before our study (Paper III) not with diverticular disease (38, 39). 
Table 5. Studies on incidence and admission rates of diverticular disease 
Study Study 
period 
Primary data 
sources 
No. of 
events 
Main 
measure(s) 
Rate estimate(s) 
Kang 
2003 
(34) 
England 
1989/1990–
1999/2000 
Hospital 
Episode 
Statistics 
(Department 
of Health) 
Not 
specified 
Admission 
rates with 
diverticular 
disease at 
National 
Health Service 
hospitals 
(excluding 
day case 
admissions) 
25.1 (1989/1990)–28.2 
(1999/2000) admissions 
per 100,000 inhabitants 
(Standardized to the 
European standard 
population) 
Warner 
2007 
(40) 
Ontario 
Canada 
1988–2002 
Discharge 
Abstract 
Database 
(Canadian 
Institute for 
Health 
Information) 
133,875 
admissions 
Admission 
rates with 
diverticular 
disease 
94 (1988)–105 (2001) 
admissions per 100,000 
inhabitants 
Jeyarajah 
2009 
(41) 
England 
1996–2006 
Hospital 
Episode 
Statistics 
(Department 
of Health) 
560,281 
admissions 
Admission 
rates with 
diverticular 
disease at 
National 
Health Service 
hospitals 
(including day 
case 
admissions) 
56 (1996)–120 (2006) 
admissions per 100,000 
inhabitants 
 
 8 
Study Study 
period 
Primary data 
sources 
No. of 
events 
Main 
measure(s) 
Rate estimate(s) 
Etzioni 
2009 
(35) 
 
USA 
1998–2005 
Nationwide 
Inpatient 
Sample 
(representative 
sample of 
approximately 
20% of the 
hospital 
discharges 
within the 
United States) 
267,000 
admissions 
Admissions 
rates with 
acute 
diverticulitis, 
length of stay 
>0 day, 
excluding 
patients with a 
diagnosis of 
colorectal 
cancer 
58.9 (1998–1999)–71.0 
(2004–2005) admissions 
per 100,000 inhabitants 
(Standardized to the 
1998–1999 US 
population) 
Humes 
2009 
(42) 
United  
Kingdom 
1990–2005 
General 
Practice 
Research 
Database 
(diagnostic 
and 
prescription 
data for over 
13 million 
people of the 
general 
population in 
the United 
Kingdom, with 
3.4 million 
active patients 
contributing 
high-quality 
validated data) 
953 
incident 
cases 
Incidence 
rates of 
perforated 
diverticular 
disease 
1.75 (1990–1995)–3.27 
(2001–2005) incident 
cases per 100,000 
person-years 
(Excluding the 
population denominators 
for those under 45 years 
of age) 
Nguyen 
2011 
(33) 
USA 
1998–2005 
Nationwide 
Inpatient 
Sample 
323,097 
admissions 
Admissions 
rates with 
acute 
diverticulitis, 
length of stay 
>1 day 
61.8 (1998)–75.5 (2005) 
admissions per 100,000 
inhabitants 
(Standardized to the US 
standard population 
from 2000) 
Jamal 
2014 
(43) 
Levanger  
Hospital 
(serving a 
defined 
population), 
Norway 
Hospital 
patient 
administrative 
system and 
individual 
review of 
medical 
records 
851 
admissions 
in 650 
patients 
1) Admissions 
rates with 
acute 
diverticulitis 
2) Incidence 
rates with 
acute 
diverticulitis 
1) 17.7 (1988–1992)–
51.1 (2008–2012) 
admissions per 100,000 
person-years 
2) 15.6 (1988–1992)–
38.6 (2008–2012) 
incident cases per 
100,000 person-years 
Bharucha 
2015 
(36) 
Olmsted 
County 
USA 
1980–2007 
Rochester 
Epidemiology 
Project 
database 
3,222 
cases with 
an initial 
(index) 
diagnosis 
of 
diverticulitis 
Incidence 
rates of acute 
diverticulitis, 
outpatients 
and inpatients 
combined 
115 (1980–1989)–188 
(2000–2007) incident 
cases per 100,000 
person-years 
(Standardized to the 
United States 
white population in 
2000) 
Sköldberg 
2018 
(Paper III) 
Sweden 
1987-2010 
The National 
Patient 
Register 
144,107 
admissions 
in 95,049 
patients 
1) Admission 
rates with 
diverticular 
disease 
2) Incidence 
rates of 
admission 
with 
diverticular 
disease 
1) 70.8 admissions per 
100,000 person-years 
2) 47.4 incident cases 
per 100,000 person-
years  
(Standardized to the 
European standard 
population from 2013) 
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1.4.2 Association to colon cancer 
Colon cancer and diverticular disease share several characteristics. They are diseases 
mainly situated in the left colon. They have both increased admission rates the last 
decades and are more common in Western world and in elderly individuals (41, 44, 45). 
Several studies have suggested the typical Western diet of low fibre and high intake of fat 
as major etiological factors for both diseases (46-49). Other inflammatory conditions in the 
gastrointestinal tract, such as ulcerative colitis, Crohn's disease and helicobacter pylori 
infection, have been shown to increase the risk of malignancy (50-52). Therefore, an 
association between diverticular disease and colon cancer has been hypothesized. Despite 
several studies, mainly cross-sectional endoscopy- radiological- and surgical specimen 
analyses but also register-based studies, the association has been unclear due to 
contradictory results (44). Since it, in the acute state, can be difficult to distinguish 
diverticulitis and colon cancer and due to the unclarity regarding diverticulitis as a factor 
for future development of colon cancer, diverticular disease patients have in some centres 
been monitored repeatedly by various modalities for colon imaging. However, these 
routines have not been evidence-based. 
Table 6 shows a summary of current findings of association between diverticular disease 
and colorectal cancer and adenomas, including our study (paper I). 
Table 6. Main studies on association between diverticular disease and colorectal cancer and/or 
adenomas 
Study Patients Study design, type 
of examination, type 
of diverticular dis-
ease 
Association to p<0.05 
colorectal cancer adenomas advanced 
adenomas 
Sim 
1982 
(53) 
1,118 Cross-sectional 
Contrast barium 
enemas 
Diverticular disease 
None None N/A No 
McCallum 
1988 
(54) 
119 Case-control 
Contrast barium 
enemas 
Diverticulosis 
Negative N/A N/A not 
pub-
lished 
Morini 
1988 
(55) 
150 Case-control 
Colonoscopy 
Symptomatic diver-
ticular disease 
None Positive Positive yes 
Stefans-
son 
1993 
(56) 
7,159 Cohort  
Hospital discharge 
diagnoses 
Diverticular disease 
Positive (only left 
side) 
N/A N/A yes 
Morini 
2002 
(57) 
630 Case-control 
Colonoscopy 
Diverticulosis 
None Positive Positive yes 
(not for 
colo-
rectal 
can-
cer) 
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Study Patients Study design, type 
of examination, type 
of diverticular dis-
ease 
Association to p<0.05 
colorectal cancer adenomas advanced 
adenomas 
Loffeld 
2002 
(58) 
6,827 Cross-sectional 
colonoscopy 
Diverticulosis 
Negative Positive 
-polyps 
N/A yes 
Kieff 
2004 
(59) 
502 Cross-sectional 
Colonoscopy 
Positive only when 
comparing wom-
en with extensive 
distal diverticulo-
sis with women 
with none or few 
diverticula, all 
other analysis 
showed no asso-
ciation 
N/A N/A yes 
Rajendra 
2005 
(60) 
410 Cross-sectional 
Colonoscopy 
Diverticulosis 
None Positive N/A yes 
Krones 
2006 
(61) 
1,838/ 
512 
Retroperspective 
Colonoscopy, bari-
um enema, histo-
pathology 
Diverticulo-
sis/diverticulitis 
Negative N/A Negative yes 
Soran 
2006 
(45) 
1,561 Retroperspective 
Histopathology 
Diverticulosis 
 
Positive to rec-
tosigmoid cancers 
(no control group 
without colorectal 
cancer) 
N/A N/A yes 
Stefans-
son 
2004 
(62) 
7,159 
(diver-
ticulosis 
and 
divertic-
ulitis) 
64 colo-
rectal 
cancer 
123 
colorec-
tal can-
cer-free 
controls 
Nested case-
control 
Hospital discharge 
diagnoses + medi-
cal chart review 
Diverticulitis com-
pared to diverticu-
losis 
Positive -
diverticulitis- 
N/A N/A yes 
Meurs-
Szojda 
2008 
(63) 
4,241 Cross sectional 
Colonoscopy 
Diverticulo-
sis/diverticulitis 
Negative -
diverticulosis 
None -diverticulitis 
N/A Negative -
diverticu-
losis 
None -
diverticuli-
tis 
yes 
 
Lam 
2010 
(64) 
288 Retroperspective 
cohort 
Hospital discharge 
diagnoses  
+CT-scan or sur-
gery 
Diverticulitis 
Negative Negative N/A yes 
Granlund 
2011 
(Paper I) 
41,037 Nationwide popula-
tion-based case-
control 
Hospital discharge 
diagnoses 
None after 1 year 
(positive first 12 
months) 
N/A N/A yes 
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Study Patients Study design, type 
of examination, type 
of diverticular dis-
ease 
Association to p<0.05 
colorectal cancer adenomas advanced 
adenomas 
Huang 
2014 
(65) 
41,359 
 
Nationwide popula-
tion-based cohort 
Hospital discharge 
diagnoses 
None after 1 year 
(positive first 12 
months) 
N/A N/A yes 
1.5 MORTALITY  
Of the spectrum of disorders of diverticular disease, diverticulitis has gained the most 
attention when studying mortality, probably because of its impact on patients in term of 
severe symptoms and complications. One way of examining mortality is by calculating 
standardized mortality ratios in where one compares the number of subjects that died per 
year to the expected number dead in the general population with the same sex and age 
distribution. In Scotland, this was calculated by Paterson et al. for first-time emergency 
admitted diverticulitis patients 2010-2010, using mortality rates in the general population 
in groups of sex and 10-year bands of age. Increased standardized mortality ratio was 
found to be 2.81 (95% CI 2.63-3.00) for surgically treated patients and 1.78 (95% CI 1.73-
1.82) for conservative treated patients. Increased standardized mortality ratios were 
associated with female gender and younger age when surgically treated, and socio-
economic deprivation for conservative and surgically treated patients (66). Regarding 
follow-up time, when investigating mortality in diverticulitis patients, mainly short-term 
mortality after hospitalization has been studied, usually as in-hospital death proportion or 
ditto within 30 days. These have been reported to be 0.5-2.1% in conservative managed 
patients (67, 68, 69). Regarding surgically treated patients, Haas and colleagues reported 
in 2016 an up to 30-days mortality of 3.05% (95% CI 1.73-5.32) after reviewing 59 studies 
(70). Long-term mortality is not as well studied, regarding death/survival proportion. 
Diverticulitis patients with first abscess formation (modified Hinchey Ib-II) has been 
studied as 5-year survival proportion from Kaplan-Meier statistics by Gregersen et al. in a 
Danish register-based cohort study including 3,148 patients and was found to be 66.0% 
(95% CI 63.9-68.0) in conservative treated patients and 66.7% (59.0-73.3) in surgically 
treated patients (71). Mortality was associated with male sex and glucocorticoid use. In 
Ontario, Canada, the 5-year death proportion was 14.1% in first time diverticulitis 
hospitalized patients that were treated conservative, when starting observation period 30 
days after discharge (72). Bharucha et al found, in a register-based cohort study, a 5-year 
survival proportion of 65-71% in different calendar time periods 1980-2007 in 1,502 
diverticulitis patients in Olmsted county and considered the overall survival over the study 
period not significantly different from expected in a similar (white Minnesota) population. 
Mortality was higher in older people, in women and in the most recent calendar periods 
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(36). However, those results were not adjusted for comorbidity or social factors. There is 
no nation-wide study published comparing diverticulitis patients, neither on short-term 
mortality nor long term mortality, to a sex- and age-matched disease-free group of 
individuals adjusted for comorbidity or social factors. Humes et al have published the only 
study so far comparing long-term mortality in a cohort of diverticulitis patients with an 
individually matched disease-free comparison group. This cohort of 953 individuals was 
however a subgroup of diverticulitis patients, including only those with perforated colon. 
They found a first-year HR of 5.63 (95% CI 4.68-6.77) (42). 
1.6 ETHIOLOGY AND PATHOGENESIS 
1.6.1 Diverticula structure and formation 
Diverticula are herniations of mucosal and serosal layers at sites where the blood supply 
via vasa recta penetrate the colon wall. Sometimes, they are referred to as false 
diverticula, since no muscle layer is included in the herniation. They are mainly located in 
the distal colon in the Western world (>90% in the sigmoid) and can vary from solitary 
findings to many hundreds in an individual. They are usually 5-10mm in diameter but can 
exceed 2 cm (73).  
The ethiology and pathogenesis of diverticular disease is still not fully understood. Painter 
and Burkitt proposed a theory in the 1970's suggesting that the Western diet of low fiber 
reduce stool volumes and slower transit time which promotes constipation that causes 
hypersegmentation (by increased tension of circular muscle layers and teniae coli). 
Hypersegmentation would narrow the lumen and generate higher intraluminal pressure 
according to Laplace's law (wall tension=pressure x radius), which would favor formation of 
diverticula at weakest point of the wall (where vasa recta enter, in connective tissue clefts 
in the circular muscle layer) (74). This causality theory, between low fiber content diet and 
colon wall changes, has been quite well established, but recently being questioned, as 
described further below.  
There are several studies supporting different types of structural changes in colon wall in 
diverticular disease patients. Thickening of circular muscle and shortening of coli teniae 
have been shown in necropsy studies (75-77). Imbalances in the extracellular matrix, 
which has an important role in the integrity, strength and flexibility of the colon wall might 
lead to changes in motor activity and herniation when exposed to increased intraluminal 
pressure, argues several authors (73, 78-80). A recent study has shown that thickening of 
the longitudinal muscle layer was associated with increased fractions of connective tissue 
located within the circular and longitudinal muscles. Additionally, other differences in 
smooth muscle architecture were shown, as irregular muscle bundle orientation (81, 82). 
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Some researchers suggest that smooth muscle dysfunction may result from vagal attrition 
associated with ageing (83). Tighter collagen crosslinking has also been found in 
diverticulosis patients, which might reduce submucosal compliance (= degree of elasticity), 
thereby increasing the risk for herniation (82, 84, 85).  Ulmer et al showed that 
diverticular disease patients had lower collagen I/III quotients and decreased glial cell 
(involved in the intrinsic ganglia part of peripheral nervous system, they are thought to 
have functions related to maintaining epithelial barrier integrity and regulate colonic 
motility (86, 87)) density. The authors found indices of increased proliferation and 
apoptosis in patients with complicated diverticular disease. This was however compared to 
a group of disease-free colectomy samples from colon cancer patients (that might have an 
underlying inflammatory component) (78, 79). Also comparing to disease-free colectomy 
samples from colon cancer patients, Basotti et al found similarly decreased amounts of glia 
cells but also that interstitial cells of Cajal (the gut pacemaker cells) were decreased in 
diverticulosis patients (88, 89). Several studies have actually suggested that diverticulosis 
might be an enteric neuropathy (90-93). A derangement of the myenteric nerve plexus was 
first reported by Macbathe and Hawthorne in 1965 (91). Milner et al. found that the 
neurotransmittor vasoactive intestinal polypeptide (found in the myenteric plexus and 
appears to inhibit peristalsis) levels in sigmoid colon wall was increased in diverticular 
disease patients (89, 94). Other neurotransmittors associated with colon motility as 
serotonin, acetylcholine and nitric oxide have also been suggested to play a role in 
development of diverticular disease (95). Elastin, which is a highly elastic protein in the 
connective tissue that allows mass to resume its shape after stretching or contraction, has 
shown to be increased up to 200% in taeniae coli in surgical specimens of uncomplicated 
diverticular disease. It was however no alternation of elastin content in the circular 
muscle. The authors concluded that this "elastosis" may be responsible for the shortening 
of coli teniae (which in turn leads to changes in circular muscle tension and 
hypersegmentation) (96, 97).  Interesting is, that diverticulosis is more common in patients 
with connective tissue disorders, as Ehler Danlos syndrome and Marfan syndrome (98-
100).  
Colonic transit studies show conflicting results. Both delayed and increased transit times 
have been found in diverticular disease patients (101-103). Studies of myoelectrical 
activity recordings in vivo through catheters in the colon of diverticular disease patients 
have showed unaltered or increased activity but the relevance of any changes in relation to 
mechanical events remains uncertain (95, 104-109). Manometry studies over 24 hours 
have showed an overall increase in basal motility in segments harboring diverticula, an 
abnormal motor activity response after eating and an abnormal forceful propulsive activity 
(92, 95). Some authors regard the increased intraluminal colonic pressure being a major 
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pathogenetic factor of diverticula formation while others have suggested, that these 
increased pressures are only detectable when symptoms occur (90, 110-112). An 
explanation of why diverticula are more common in the sigmoid could be that this part of 
colon has the smallest diameter and therefore least elasticity, which would contribute to 
highest intraluminal pressures (113, 114). 
In summary, pathogenesis of diverticula formation is yet unclear but structural changes in 
the colon wall, including abnormalities in muscle composition and changes in the enteric 
nervous system associated with altered motility seem to be essential elements. 
Environmental and genetic factors that are associated with presence of diverticula are 
described below.  
1.6.2 Inflammation in diverticula 
When macroscopically signs of inflammation are seen in a diverticulum together with raised 
inflammatory parameters and typically symptoms (described below), it is called 
diverticulitis. The inflammation often engages a part of the adjacent bowel and 
peridiverticular mesenteric fat, but can also spread diffusely along the peritoneal surface, 
form abscesses and involve nearby organs (14). A diverticulum can also perforate into the 
peritoneal cavity and lead to rapidly spreading purulent or faecal peritonitis (14). As 
described earlier, Hincheys classification (Table 1) is used to differentiate stages of 
perforated diverticulitis (16). Another complication is fistula to other pelvic organs as the 
urine bladder or vagina (14). Inflammation can also lead to formation of scar tissue which 
might cause strictures of the affected bowel segment, resulting in obstructive symptoms 
(14). In addition, a diverticulum can erode the arterial wall of the vasa recta and cause 
gastrointestinal bleeding (inflammation not required) (14, 115, 116). The bacteria involved 
in abscesses and peritonitis secondary to diverticulitis typically originate from the normal 
colon flora (14). Anaerobes as bacteroides fragilis, Escherchia coli, Klebsiella 
enterobacteria and Enterococcus species are commonly seen (14, 117-119).  
Entrapment of faecoliths within a diverticulum causing microperforation and abscess 
formation, or ischemia or mechanical injury at the neck of the diverticula, has been 
explained as the pathogenesis behind diverticulitis (27). Recently, several other 
mechanisms of pathogenesis have been suggested, described below. Furthermore, the last 
few years, a new subclass of diverticular disease has been suggested, Symptomatic 
Uncomplicated Diverticular Disease (SUDD). It is defined as diverticulosis with associated 
chronic abdominal pain in the absence of acute symptoms of diverticulitis or overt colitis 
(89). This condition might have a different pathogenesis than diverticulitis. Chronic low-
grade inflammation localized in the mucosa has been suggested as a factor (120). Increased 
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number of mast cells in all the layers of the colonic wall has been shown in these patients 
as well as microscopic infiltrates with lymphocytes and neutrophils (121-124). Some 
authors even conclude that low-grade macroscopic inflammation could be evident in these 
patients. There seem, however, to be different diagnostic criteria used in studies when 
including patients with SUDD, from "presence of abdominal pain and change in bowel 
habits attributed to diverticula in the absence of alternate etiologies" to presence of any 
symptoms in diverticular disease (and excluding diverticulitis) (30). Low-grade mucosal 
inflammation has also been described in irritable bowel syndrome (IBS) (125). There have 
also been studies showing signs of visceral hypersensitivity in SUDD, as well as in 
inflammatory bowel disease (IBD), which might explain some of the symptoms (125-127).  
The gut microbiome in diverticulosis, SUDD and diverticulitis has been studied by some 
authors, as it has been found that a disruption of the homeostatic microbial balance 
(dysbiosis) being associated with other gastrointestinal diseases, as inflammatory bowel 
disease (82, 128-133). Some of the studies analyzed fecal bacteria while others mucosal 
bacteria. The first mentioned could be different from those inside the diverticulum because 
of the anatomically limited communication with the lumen (82). Several species of bacteria 
have been found to be either increased or decreased compared to controls but because of 
small sample sizes, different bacterial identification methods and use of control groups that 
might harbor a confounding dysbiotic microbial composition, it is difficult to identify 
common bacteria that influence disease (82). The host immune response has also been 
investigated in diverticulitis using RNA-sequencing of resected sigmoid colon tissue from 
patients with quiescent disease. Although examination of the tissue did not show gross 
inflammation, both the innate and the adaptive immune system pathways were enriched 
compared to in non-diverticulosis individuals (82, 134). 
Segmented colitis associated with diverticulitis (SCAD), is currently considered a separate 
disorder (135). It is described as non-specific segmental inflammation in the sigmoid colon 
surrounded by multiple diverticula (135, 136). The diverticular orifices do not need to be 
involved (135, 137). SCAD shares several features of IBD and infectious and ischemic 
colitis. Cryptitis, crypt abscesses and granulomas have been described in SCAD-patients. 
(89, 138). It appears to be a mainly benign and self-limiting condition (135, 136) but some 
authors suggest that it might develop into IBD in a small subset of patients (139). 
1.6.3 Genetic susceptibility 
Until our twin study in 2012, based on data from Swedish Twin registry, little research had 
been published regarding genetic susceptibility (Paper II). Several case reports describing 
diverticular disease among siblings and twins had been published (140-145), including 
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European and African patients, and several genetic diseases as Ehlers Danlos syndrome, 
William-Beuren syndrome, Coffin-Lowry syndrome and polycystic kidney disease have 
been associated with higher risk of diverticular disease which could imply a genetic 
component (146-151).  
Diverticula are more common and mainly located in the left part of the colon in the 
western world compared to in the right part of the colon in Asians (152). Furthermore, it 
had been shown that incidence and prevalence of diverticulosis and diverticulitis differ 
widely between different ethical groups in the same geographical area (153-158). Burkitt 
and Painter suggested this difference might be due to lifestyle factors as the typical 
Western diet of low fiber (10). It was indeed shown in the 1970's that prevalence of 
diverticular disease was higher among Japanese that migrated to Hawaii compared to those 
staying in Japan, which could support the theory of altered lifestyle habits as a cause of 
the disease (159). Hjern et al. found, in accordance, in a Swedish registered based study, 
lower risk of hospitalization for diverticular disease for non-western immigrants compared 
to natives, and that the risk increased the longer they lived in Sweden (160). More 
intriguingly, Miura et al. found that the increase incidence in diverticulosis in Japan 
(analyzed as review of medical chart of barium enema examinations) in the 1980's and 
1990's, a time when the country was increasingly influenced by western culture, was only 
apparent for right side and not left side diverticulosis (161).  
Our study from the Swedish Twin Registry was based on 104,452 twins, including 2296 
with diverticular disease, demonstrating an estimated heritability of 40% (Paper II). Strate 
et al published the following year a study based on the Danish twin registry but also in a 
separate analysis including siblings to an index case. The twin analysis included 923 twins 
with diverticular disease (diagnosed at hospitalization, or in the later time period, at 
outpatient visits) of 60,644 twins. Results were similar to our study, with an estimated 
heritability of 53% (95% CI 45-61%). The sibling analysis showed an increased relative risk 
for diverticular disease in siblings of 2.92 (95% CI 2.50-3.39) (162). 
Since 2014, several gene candidate driven studies have been performed searching for 
single nucleotide polymorphisms (SNPs) and other variants in DNA that could be 
associated with diverticular disease. The first SNP that was associated with diverticular 
disease was rs7848647 on the TNFSF15 (Tumour necrosis superfamily 15)-gene. This 
gene has earlier been associated with IBD and is involved in T-receptor maturation. It was 
found that diverticulitis patients requiring surgery to a greater extent had genotypes 
including the nucleotide guanine, compared to IBD patients and healthy controls (163). In 
a follow-up haplotype analysis on TNSFS15-gene including the above-mentioned SNP, an 
association with diverticulitis was found (164). An exome sequencing study identified a rare 
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single nucleotide variant in the laminin b 4 gene (LAMB4) in diverticulitis patients. This 
gene is involved with laminins which are constituents of the extracellular matrix and play a 
role in functions of the enteric nervous system (165). This might support the role of 
dysmotility as part of the pathogenesis of diverticular disease. Another SNP, (rs3134646) 
in collagen type III alpha 1 chain (COL3A1) gene was associated with diverticulosis in 
white men. This finding might support the role of collagen vascular system in the 
pathogenesis (82, 166).  
In 2017, the first genome-wide association study (GWAS) was made on diverticular disease 
patients from Iceland and Denmark. Common sequence variants in introns (part of the 
nucleotide sequence that are removed in the final RNA product) of the genes ARHGAP15 
(involved in cell proliferation apoptosis, attachment and motility), COLQ (encodes a 
molecule that is associated with acetylcholinesterase) and FAM155A (unknown function 
but close SNPs have been associated with increased fat mass in children and anorexia) was 
found in these patients. These sequence variants do not overlap with other known signals 
in other diseases or traits found in other GWAS. However, no significant differences were 
seen in expression of the target genes or nearby genes, therefore these differences are of 
unknown functional impact (82, 167). 
1.6.4 Environmental factors 
1.6.4.1 Diet 
As described in chapter 1.6.1 "Diverticula Structure and Formation", Painter and Burkitt 
suggested in the 1970's that diet with low fiber content is an important cause of diverticula 
formation (10). This hypothesis originated from their discovery that prevalence of 
diverticulosis in African countries, where high consumption of fiber is common, was much 
lower than in Western countries with a deficiency in fiber intake.  
Aldoori et al found in a prospective cohort study that low fiber intake was associated with 
risk of symptomatic diverticular disease (168). In a follow-up study, they suggested that 
the insoluble component of fiber, particularly cellulose, was negatively associated with 
symptomatic diverticular disease (169). Crowe at al found in a prospective cohort study, 
that consuming a vegetarian diet and a high intake of dietary fiber were both associated 
with a lower risk of admission to hospital and death from diverticular disease (170). The 
same authors concluded in a follow-up study that cereal and fruits had the strongest 
negative association for these events (171). Mahmood et al found that high intake of 
dietary fiber from fruit and vegetables decreased the risk of hospitalization for diverticular 
disease, in two major cohorts, The Swedish Mammography Cohort and the Cohort of 
Swedish Men. In their study, intake of cereals did not influence the risk (172). Strate et al 
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studied incidence of diverticulitis in diverticulosis-free men (no earlier known diagnose of 
diverticulosis) with Western diet (high in red meat, refined grans, and high-fat dairy) 
compared to prudent diet (high in fruits, vegetables, and whole grains). The highest 
quintile of western dietary pattern score had a HR 1.55 (95% CI 1.20-1.99) of diverticulitis 
compared to ones in the lowest quintile. High vs low prudent scores were associated with 
decreased risk of diverticulitis (HR 0.74, 95%CI 0.60-0.91) (173). 
However, recent studies on diverticulosis show different associations of dietary fiber. In 
2013-2014, Peery et al published two articles of cross-sectional analyses of individuals 
that underwent outpatient colonoscopy and found that asymptomatic diverticulosis was 
associated with high intake of dietary fibers. Moreover, they reported that these patients 
had increased and not decreased frequency of bowel movements. They suggested that the 
diet recommendations of higher fiber intake should be reconsidered since they were of low 
scientific quality (174, 175). There might be different risk factors concerning dietary fiber 
for diverticula per se and development of symptomatic disease. Based largely on these 
data, the recent American Gastroenterology Association (AGA) guidelines on diverticulitis 
suggest a high dietary fiber intake in patients with explicitly a history of acute diverticulitis 
(176, 177). 
Other dietary factors that have been studied are red meat/fat, alcohol, nuts/corn/popcorn 
and caffeine intake. High red meat and high fat diets have been associated with 
symptomatic diverticular disease (168) and red meat with incidence of diverticulitis in men 
(178).  Intake of nuts, corn or popcorn did have an inverse association to diverticulitis and 
diverticular bleeding, the controversy of earlier common beliefs, as it has been thought 
that these small food particles could get caught in the diverticula and cause inflammation 
(179). Studies of alcohol use and diverticulosis respectively symptomatic diverticular 
disease show conflicting results (175, 180-182). Caffeine intake did not substantially 
increase risk for symptomatic diverticular disease in a prospective cohort study (180). 
1.6.4.2 Vitamin D 
Among patients with diverticulosis, higher pre-diagnostic levels of vitamin D (25(OH)D) 
were associated with a lower risk of diverticulitis (183). In a follow-up study, the authors 
found that low UV (ultraviolet) light exposure was associated with an increased rate of 
diverticulitis admissions and higher seasonal variation. Since UV light exposure determines 
a large part of the vitamin D status, they conclude that these findings support a role for 
vitamin D in the pathogenesis of diverticulitis (184). 
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1.6.4.3 Smoking 
Smoking has been associated with an increased risk of diverticulosis, hospitalizations for 
diverticular disease and diverticulitis as well as more complications and increased rate of 
recurrent diverticulitis episodes after surgical treatment of diverticulitis (175, 185-188). 
1.6.4.4 Obesity/Physical activity 
A pro-inflammatory state is thought to be the mechanism through which obesity could 
contribute to diverticular disease (79). Obesity has been found to increase the risk for 
diverticulosis, hospitalization for diverticular disease and diverticulitis as well as 
diverticular bleeding (175,185, 189-191). Pilgrim et al concluded in a systematic review of 
23 clinical case series that the majority of diverticulosis patients aged <40 years were 
obese (192). Hjern et al found that obese (BMI ³30) women had a twofold (RR 2.00, 95% 
CI 1.08-3.73) risk of complications as perforation and abscess (191). The same authors 
showed that low physical activity, defined as exercise ≤ 30 min/day, increased the risk for 
hospitalization for diverticular disease with 42% (RR 1.42, 95% CI 1.18-1.69) compared to 
exercise >30 min/day, in women (191). Strate et al found similarly decreased risk of 
diverticulitis and diverticular bleeding with physical activity, in a cohort of men from the 
Health Professionals Follow-up study (193). Just recent, Järbrink-Sehgal et al. published a 
Swedish register-based study including 43,772 men aged 18-20 years conscripted to 
military service and followed for a period of 39 years. It was found that overweight and 
obese men had a 2-fold increased risk of hospitalization for diverticular disease compared 
to normal-weight men; HR 2.02, (95% CI 1.50-2.73) (194). 
1.6.4.5 Drugs 
Corticosteroids are known to alter responses to inflammation and infection and their 
chronic use reduces collagen turnover (195). Several authors have reported that use of 
corticosteroids may weaken the colon wall and increase risk of perforation in diverticulitis 
(188, 196). Hjern et al found in a population-based cohort study of 37,000 middle-aged 
women that use of oral and inhaled corticosteroids also increased the risk for 
hospitalization of diverticular disease with 37% (RR 1.37, 95% CI 1.06-1.78) and 71% (RR 
1.71, 95% CI 1.36-2.14), respectively. A significant dose-response relationship, with the 
risk increasing the longer duration of inhaled corticosteroids was seen (195). Patients with 
perforated diverticulitis had a two-fold increased risk of dying when using corticosteroids 
compared to non-users, but no dose-response relationship was apparent (197). 
Non-steroid inflammatory drugs (NSAID) are thought to induce mucosal damage due to its 
reduction of prostaglandin synthesis (198). They have in some studies been found to 
increase the risk for diverticulitis, diverticular bleeding and diverticulitis perforation (196, 
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198, 199) while others have not found any significant increased risk of hospitalization for 
diverticular disease or diverticulitis perforation (188, 195). 
Opioids have shown to double the risk for diverticulitis perforation in a case-control study 
of Humes et al (188) and similarly in a study by Morris et al (196). 
Strate et al reported increased risks for both diverticulitis and diverticular bleeding in the 
Health Professionals Follow-up Study cohort of men with Aspirin (198) whereas Humes et 
al (188), and Morris et al (196) did not find any influence of Aspirin use on perforated 
diverticulitis. In addition, Hjern et al found no increased risk of diverticular disease 
hospitalization in their cohort of women (195). 
Calcium blockers show no influence in perforated diverticulitis but might increase the risk 
for diverticular bleeding according to a systematic review (200). 
Statin use did not affect the development of symptomatic diverticular disease but was 
associated with a reduced risk of emergency surgery for diverticulitis in a nation-wide 
population-based case-control study by Sköldberg et al (201). 
1.7 CLINICAL FEATURES AND HEALTH CARE MANAGEMENT 
1.7.1 Diverticulosis 
Diverticulosis, is commonly found en passant when patients are investigated with 
endoscopy or radiological modalities for different indications. Recent studies have shown 
that presence of diverticula represent the most common non-neoplastic finding during 
screening colonoscopy (202, 203) There is no routine follow-up for these patients as most 
of them will not develop any symptoms related to diverticulosis. However, healthy lifestyle 
(regular physical exercise, maintaining ideal body weight, abstention from smoking) has 
been recommended to prevent progression to a symptomatic state (170, 202). The 
recommendation of a high-fiber diet in these patients is still under debate (170, 176, 177). 
1.7.2 Symptomatic uncomplicated diverticular disease (SUDD) 
When a patient with diverticula develop chronic gastrointestinal symptoms such as 
abdominal pain, bloating or change of bowel habits without any clinical sign of acute 
inflammation, the term SUDD has lately been used. The incidence of SUDD and other 
problems in patients with diverticulosis is not well studied, but may occur in 15% of 
diverticulosis patients according to a health questionnaire study (202, 204). In a 
population-based study of 745 randomly selected adults, including 130 with diverticulosis 
(none with an earlier diverticulitis episode), Järbrink-Sehgal et al found that diverticulosis 
patients were more likely to report loose stools, urgency, passing mucus, and a high stool 
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frequency than diverticulosis-free individuals. Diverticulosis was associated with abdominal 
pain and diarrhea-predominant IBS in participants older than 60 years (30). Symptoms of 
IBS and SUDD widely overlap (205). An Italian survey found that 59% of SUDD patients 
fulfilled the Rome III criteria for IBS (206). The age distribution is however different 
between the two conditions, SUDD is most common in older individuals while IBS is 
predominantly diagnosed in younger ages (202). Several studies have been conducted 
trying to discriminate symptoms of the two diseases (206, 207, 208). Some authors have 
suggested that a positive fecal-calprotectin test can differentiate SUDD from IBS (207, 
209, 210). It has also been found that patients have an increased risk of being diagnosed 
with IBS after an episode of diverticulitis (211). Whether this post-diverticulitis condition 
should be classified as SUDD instead is discussed. Many still consider SUDD as a 
coincidence of diverticular disease and IBS (212). 
Several drugs, including rifaximin (a poorly absorbed antibiotic used in treatment of small 
intestine bacterial overgrowth and related disorders) and mesalazine (an anti-inflammatory 
and antioxidant substance used in treatment of ulcerative colitis), as well as probiotics 
have been suggested as new therapies in SUDD but there is still no strong 
recommendation for such use (202). 
1.7.3 Diverticulitis 
1.7.3.1 Clinical findings 
Diverticulitis develops in an estimated 4-25% of patients with diverticulosis (32, 213). 
After a first episode of diverticulitis, 9-30% of patients have at least one recurrence (214-
216, 67) and the risk of recurrence increases with the number of episodes (36).  
Symptoms of diverticulitis are typically abdominal pain in the left lower quadrant, and 
temperature >38 degrees centigrade. Diarrhea or constipation, bloating, nausea and 
vomiting and an increased urge to urinate are common. Palpation tenderness in the left 
lower quadrant is a classical sign of diverticulitis. On physical examination, peritoneal 
signs such as défense musculaire, rebound tenderness or Rovsing's sign can be apparent 
while signs of generalized peritonitis as rigid abdominal wall, non-localized tenderness, 
absent bowel sounds can appear in patients with perforation to free abdominal cavity. In 
severe cases with free perforation, patients become hemodynamically instable. 
C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) are usually increased.  
Cross-sectional imaging is recommended in most international guidelines and computed 
tomography (CT) is routinely used in Scandinavia (212). It has a good diagnostic accuracy 
with reported sensitivity of 93-98% and specificity of 75-100% (73) and therefore has 
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replaced contrast barium enema, which earlier was the investigation of choice. Patients 
with diverticulitis have CT findings including (217): 
• pericolic stranding, often disproportionately prominent compared to amount of 
bowel wall thickening,  
• segmental thickening of bowel wall,  
• enhancement of colonic wall (usually inner and outer high-attenuation layers, with 
a thick middle layer of low attenuation) 
• extravasation of air and fluid into the pelvis and peritoneal cavity seen at 
diverticular perforation 
• abscess formation that may contain fluid, gas or both 
• fistula formation with gas in the bladder or with direct visualisation of a fistulous 
tract (in the case of colovesical fistula) 
In some countries, ultrasound is frequently used instead of CT (212). 
1.7.3.2 Treatment of uncomplicated diverticulitis 
Uncomplicated (absence of perforation, abscess, fistula, obstruction or bleeding) acute 
diverticulitis has been regarded as accounting for 75% of the diagnoses of symptomatic 
diverticular disease (218). If the patients have mild clinical symptoms and known 
diverticulosis they can be managed in primary care but often patients visit the emergency 
department at the hospital. The traditional care of uncomplicated diverticulitis is 
antibiotics, sometimes fluid, and bowel rest in hospital (219, 220). Antibiotics include 
trimetoprim-sulfametoxazol, metronidazol, ciprofloxacin and imipenem/cilastatin. In recent 
years, this management has been questioned as the guidelines mainly rely on uncontrolled 
studies (221, 222). Some studies, including multicenter randomized trials, have shown that 
antibiotics have no additional beneficial effect in these patients (223-226). Also, it has 
been found that patients with uncomplicated acute diverticulitis with or without antibiotics 
can be treated safely in an outpatient setting (221, 227). Thus, many patients with 
uncomplicated disease, being able to maintain hydration themselves at home, are now 
managed as outpatients, and antibiotics are no more routinely used in Swedish hospitals 
(212). 
1.7.3.3 Treatment of complicated diverticulitis  
Diverticulitis with abscess formation (Hinchey I and II) is usually treated with antibiotics 
only if of small abscess size (<3 cm) while larger abscesses are percutaneously drained 
when possible. Operative drainage is considered for very large abscesses (>5 cm) if 
percutaneous drainage is not feasible (212).  
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Diverticulitis with perforation (Hinchey III and IV) is often diagnosed by extraluminal air or 
fluid on CT-scan. Some hospitals routinely perform diagnostic laparoscopy in cases with 
these findings while others reserve operative treatment to patients with clinical findings of 
diffuse peritonitis and hemodynamically unstable patients (212). The more conservative 
management has been regarded as safe in two recently published cohort studies (228, 
229). Purulent peritonitis is treated surgically. Hartmann’s procedure (primary resection 
of the affected bowel segment and proximal colostomy), primary resection with anastomosis 
or the rather new technique laparoscopic lavage (230) are the main options. Angenete et al 
found in the randomized controlled trial DILALA, that laparoscopic lavage was safe in 
these patients (231). Other similar studies have shown different results but inclusion 
criteria have varied, including also additional Hinchey grades (232, 233). Feculent 
peritonitis (Hinchey IV) is most commonly treated with Hartmann's procedure (212). 
Earlier international guidelines recommended elective sigmoid resection following two 
episodes of medically treated diverticulitis (213, 234, 235). Lately, this has been 
questioned and most guidelines now recommend elective sigmoid resection on an individual 
basis and preferably on patients with recurrent disease with difficult complications (236-
239). Laparoscopic resection is preferred in most cases (240). A recent study found that 
the first occurrence of diverticulitis is the most complicated in a majority of cases and 
subsequent readmissions are often milder (241). It has been thought that young individuals 
have a more aggressive disease course than older individuals. Shahedi et al found that 
younger patients with diverticulosis had an increased risk of diverticulitis in a 
retrospective health registry study on veterans in Los Angeles, US (>97% males) (32). 
However, a in recent review article Pilgrim et al found that younger diverticulitis patients 
had lower rate of complicated disease than older (cut-off age 50 years) (192).  
1.7.3.4 Follow-up 
In most hospitals in Scandinavia, a colon examination is routine after an episode of acute 
diverticulitis (except if this is recently done), usually with colonoscopy and sometimes with 
CT colonography. The purpose is to rule out a missed colorectal cancer since the 
conditions may be difficult to distinguish in the acute clinical setting (212). Recent review 
articles have found that the risk of a misdiagnosed colorectal cancer is higher in 
complicated diverticulitis than uncomplicated disease (242, 243). 
1.7.4 Diverticular bleeding 
Bleeding from diverticula is the most common cause of acute lower gastrointestinal 
bleeding (244). In a study of hospitalizations of diverticulitis and diverticular bleeding, it 
was found that the prevalence of diverticular bleeding was approximately one third of that 
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of diverticulitis and that older patients are over-represented (with a peak prevalence in 
the age of 80+) (245). About 10% of diverticular bleeding patients without definite therapy 
will experience a recurrence within one year (246). 70-80% of cases of diverticular bleeding 
will resolve spontaneously (247). Scintigraphy, angiography and colonoscopy can be used 
to localize the bleeding vessel and the two-last mentioned also for therapeutic 
interventions (248).  
1.7.5 Segmental colitis associated diverticulosis syndrome (SCAD) 
SCAD is a rare condition in patients with diverticula and is currently included in some 
diverticular disease classifications. It is defined as a non-specific segmental or localized 
inflammatory process around diverticula and rectum is not involved. At endoscopy 
inflammation can be present within the inter-diverticular mucosa without necessarily 
involving diverticular orifices (136). It occurs predominantly in older males, usually 
discovered following an initial presentation with rectal bleeding (>70%) (136). It is many 
times self-limited and also responsive to oral 5-aminosalicylate (5-ASA). Sometimes 
however, chronically and symptomatic disease develop or recurrent separate episodes 
follow. If so, corticoids can be used and eventually surgical resection (136).
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2 AIMS 
The overall aim is to acquire deeper epidemiological knowledge of diverticular disease. 
Specific aims are to contribute in answering the following questions: 
1. Is hospitalization for diverticular disease associated with an increased risk of 
colorectal cancer? (Paper I) 
2. Is heretability contributing to the occurence of diverticular disease? (Paper II) 
3. What are the admission rates and incidence rates of hospitalizations and surgery 
for diverticular disease? What is the risk of hospitalization and surgery during the 
remaining lifespan? (Paper III) 
4. How deadly is diverticulitis needing hospital care? (Paper IV)
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3 PATIENTS AND METHODS 
The present thesis comprises four quantitative studies. Patients and controls were derived 
from the Swedish national quality registries described below in details. Table 7 shows an 
overview of the number of patients, study periods and study designs used. 
Table 7. Overview of studies 
 Paper I 
Association to 
colon cancer 
Paper II 
Heritability 
Paper III 
Incidence -
Lifetime risk 
Paper IV 
Mortality 
Study design Register based 
case-control 
Register based 
twin study 
Register based 
cohort 
Register based 
cohort with 
comparison 
group 
Number of 
individuals 
included 
41,037 cases with 
colon cancer from 
Swedish Cancer 
Registry 
82,074 colon 
cancer-free 
controls 
104,452 twins 
from the Swedish 
Twin Register of 
which 2,296 with 
diverticular 
disease in the 
National Patient 
Register 
95,049 with 
diverticular 
disease in the 
National Patient 
Register 
83,461 with 
diverticulitis in the 
National Patient 
Register 
812,942 
diverticulitis-free 
in the comparison 
group 
Study period 1987-2006 1969-2009 1987-2010 1990-2010 
3.1 DESCRIPTION OF THE SWEDISH NATIONAL QUALITY REGISTERS 
In Sweden, all citizens are assigned a unique identifier, the national registration number, at 
birth. The national number is registered together with other relevant personal information 
in the national quality registries. By record-linking the national quality registries through 
the national registration number, large quantities of data can be attained for research 
projects. Below is a description of the national quality registries used in this thesis. 
3.1.1 Register of the Total Population 
The Register of the Total Population was initiated 1968, after the Swedish population data 
had been computerized and is maintained by the government agency Statistics Sweden 
("Statistiska Centralbyrån"). Data is updated daily from the Tax Agency.  It contains 
information of birth, death, civil status, name changes, family relationships, and place of 
residence of all Swedish citizens. Nearly 100 per cent of births and deaths, 95 per cent of 
immigrations and 91 per cent of emigrations are registered within 30 days and with a 
higher proportion over time. It is estimated that there is over-coverage to 0.25-0.5 per 
cent of the total population, including missed registered emigration and deaths abroad 
(249). 
 28 
3.1.2 National Patient Register 
The National Patient Register was established in 1964 and is maintained by government 
agency Swedish National Board of Health and Welfare, "Socialstyrelsen". Its main part, the 
Inpatient Register, contains all discharges from hospitals. By year 1977, 19 of 26 counties 
were represented, including all great city regions, and from 1987, all hospitals in Sweden 
were included. It includes up to eight discharge diagnoses; patient’s place of residence; 
and hospital, clinic and surgical procedures. The coverage of this part of the register is 
estimated to 99 per cent (250, 273). Another part of the register covers patients treated 
in day surgery (not admitted to hospital, from 1997) and specialized open care (from 2001). 
3.1.3 Swedish Twin Register 
The Swedish Twin Register was founded at Karolinska Institutet in 1961 and is considered 
to be the largest of its kind in the world. It contains close to 200 000 twins born in 
Sweden, covering all same-sexed twin births since 1886, and all twin births since 1906. 
Zygosity has predominantly been assigned based on questions about intrapair similarities in 
childhood. This method has been validated repeatedly with DNA as having 98% or higher 
accuracy. The database is updated regularly with information about cancer diagnoses, 
hospital discharges and inpatient diagnoses, conditions during birth, cause of death and 
vital status by record-linkage from relevant national health care registries (251, 252) 
3.1.4 Swedish Cancer Registry 
The Swedish Cancer Registry was established in 1958 and is maintained by the government 
agency Swedish National Board of Health and Welfare, "Socialstyrelsen". It is compulsory 
for every health care provider in Sweden to report new cancer cases to the register. This 
includes cases diagnosed at clinical-, morphological-, other laboratory examinations, as 
well as cases diagnosed at autopsy. Six regional registries associated with the oncological 
centres in each medical region of the country do the registration, coding, major check-up 
and correction work. The regionalization enables a close contact between the registry and 
the reporting physicians which simplifies the task of controlling data. The coverage is 
estimated to be 96% of all diagnosed cases (253, 254). 
3.1.5 Swedish Cause of Death Register 
The Swedish Cause of Death Register was originally established in 1749 and registers all 
deaths in Swedish inhabitants. The recent register is maintained by the government agency 
Swedish National Board of Health and Welfare, "Socialstyrelsen" and contain data from 
1961 and is updated every year. The death cause diagnoses are registered as the 
international version of the World Health Organisation's ICD (International Classification 
of Disease). Both all diagnoses contributing to death and underlying death cause are 
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registered. It is mandatory for physicians to report death causes to the register, which is 
done in > 99 per cent of all deaths (255). 
3.1.6 Total Registry of Educational Participation 
The Total Register of Educational Participation was established in 1985 and is maintained 
by government agency Statistics Sweden, "Statistiska Centralbyrån". The register 
comprises achieved education in all Swedish citizens aged 16-74 years old. From 2007, 
citizens aged over 75 years of age are also included. Highest education attained and 
completion year are the main variables. Educations covered are primarily secondary school 
education, adult education, undergraduate education and postgraduate education. It is 
updated yearly (256). 
3.2 STUDY DESIGN 
3.2.1 Paper I -Association to colon cancer 
In this nationwide register-based case-control study, associations between diverticular 
disease and colon cancer were examined. We included 41 037 patients (cases) (52% 
females, median age females 75, and men, 73 years), diagnosed with their first colon 
cancer in the Swedish Cancer Registry from 1992-2006. The cases were divided into 
subgroups according to the localization of the tumor (left- or right-sided). All cases were 
individually matched by gender, age and calendar year of diagnosis with two controls, not 
having had any diagnose of colon cancer in The Swedish Cancer Registry up until the time 
for the cases' diagnoses. 
The exposure was hospitalization for diverticular disease, registered in the National 
Patient Register (ICD-9 code 562B 1987-1996 and ICD-10 K57.2-K57.9 1997-2006 as 
main or secondary diagnoses) prior to the dates the cases were diagnosed with colon 
cancer. As an indicator of severity of diverticular disease, the number of hospitalizations 
for diverticular disease, before the time of colon cancer diagnosis, was calculated and 
categorized. For comparison over time, the study period was divided into three calendar 
time intervals, according to the cases date of colon cancer diagnoses. The time between 
diagnose of diverticular disease and colon cancer was categorized as 0-6, 7-12, 13-18, 
19-24 and 25+ months. In separate analyses, outcome of death (of all causes and caused 
by colon cancer) was compared between cases that had been admitted for diverticular 
disease and those who had not. 
3.2.2 Paper II -Heritability 
To assess heritability in diverticular disease, we performed a national twin study. Twin 
studies take advantage of the fact that monozygotic twins share 100% of their genome, 
 30 
whereas dizygotic share on average 50%. With the traditional twin study design, it is 
possible to estimate the relative importance of genes and environmental factors to the 
development of a disease.  
Twins with known zygosity, in the Swedish Twin Registry born between 1886 and 1980 and 
not dead before 1969 were included. Twins with diagnoses of non-infectious colitis and 
coeliac disease were excluded to avoid misclassification (for diagnose codes, see Appendix 
Table A4). Since we in in Paper I had found that there seems to be a proportion of patients 
with colon cancer initially being misdiagnosed as diverticular disease, we excluded twins 
diagnosed with colon cancer (ICD-7 codes 1530–1533 and 1538–1539) in The Swedish 
Cancer Registry before, and 2 years after diagnosis of diverticular disease.  
Outcome in this paper was hospitalization for diverticular disease in the National Patient 
Register (primary and secondary diagnoses ICD-8 [1969–1986]: 562,10, 562,11, 562,18 
and 562,19. ICD-9 [1987–1996]: 562B. ICD-10 [1997–2009]: K57.2–K57.9). In order to 
analyze the severity of disease, we also analyzed primary diagnoses for diverticular disease 
separately. 
Twins were divided into groups of monozygotic, same sex dizygotic and opposite sex 
dizygotic pairs. Concordant pairs were twin pairs in which both twins had been 
hospitalized or not hospitalized for diverticular disease, while in discordant pairs, one of 
the twins had been hospitalized with diverticular disease. 
3.2.3 Paper III -Incidence and lifetime risk 
In this nation-wide register-based cohort study, incidence and lifetime risk of 
hospitalization and surgery for diverticular disease was assessed. All Swedish residents 
during 1987-2010 constituted the study base. 
The events of interest in this study was 1) hospitalization for diverticular disease and 2) 
surgery for diverticular disease. These two events were identified by use of ICD codes and 
procedure codes recorded in the National Patient Register (Please refer to Appendix Table 
A5 for codes). Further definitions of the events are described below: 
3.2.3.1 Hospitalization for diverticular disease 
All records since 1970 of hospitalization with a primary diagnostic code for diverticular 
disease in the National Patient Register were identified. Some adjustments were made to 
minimize classification bias. Patients that received a primary diagnostic code for 
peritonitis, abscess or fistula together with a secondary diagnostic code for diverticular 
disease were also included, with the additional criterion that no concomitant secondary 
diagnoses of colorectal cancer, Crohn's disease or ulcerative colitis, appendicitis or 
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mesenteric ischemia were present. Furthermore, any hospitalization with a procedure code 
for endoscopy in the colon were excluded, in order to reduce the number of patients who 
received a diagnostic code for diverticular disease merely as a result of in-hospital 
investigation (possibly reflecting presence of diverticula rather than symptomatic 
diverticular disease). To avoid including colon cancer misclassified as diverticular disease, 
any hospitalization with a concomitant diagnosis of colon cancer in the Swedish Cancer 
Registry, were excluded from the analyses. In this paper, individuals with concomitant 
diagnosis of lower gastrointestinal bleeding were tallied, but not excluded.  
3.2.3.2 Surgery for diverticular disease 
For the analyses of diverticular disease treated by surgery, only hospitalizations with any 
of the procedure codes for colorectal resection or stoma formation were included. Since 
endoscopy is occasionally performed per-operatively, hospitalizations with surgery and a 
concomitant procedure code for endoscopy were also included. 
3.2.4 Paper IV -Mortality 
In this nationwide register-based cohort study, mortality among hospitalized diverticulitis 
patients was investigated. Any individuals, aged ³30, diagnosed 1990-2010 with a first-
time hospitalization for diverticular disease as primary diagnosis code, or as secondary 
diagnosis code together with primary diagnostic code for peritonitis, abscess or fistula in 
the National Patient Register, were included (257). Type of treatment during 
hospitalization, surgical (colorectal resection or stoma formations) or conservative (no 
colorectal resection or stoma formations), was registered by procedure codes in the same 
register. Please refer to Appendix Table A5 for codes. 
Several exclusions were made to obtain a cohort that was hospitalized for diverticulitis. 
Similarly, as we did in papers II and III, any individual with a diagnosis of colorectal cancer, 
according to the Swedish Cancer Registry, registered within a year after the 
hospitalization for diverticulitis, were excluded, to avoid misclassification. Furthermore, we 
excluded any individual with a primary or secondary diagnosis of gastrointestinal bleeding 
during hospitalization for diverticulitis. Diverticula commonly bleed without obvious 
inflammation or any other symptoms of diverticulitis. Any individual with a procedure code 
for endoscopy but no procedure code for colorectal resection or stoma formation, at the 
admission, were excluded for the same reasons as in Paper III.  
Among patients with a primary diagnosis of peritonitis, abscess or fistula and a secondary 
diagnosis of diverticular disease, any individuals were excluded if they had a concomitant 
diagnostic code for colorectal cancer, inflammatory bowel disease, vascular disorder of the 
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intestine or appendicitis in National Patient Register during the same hospitalization, as in 
Paper III. Please see Appendix Table A5 for codes.  
The diverticulitis cohort defined above, was compared to a disease-free cohort without 
any prior history of diverticulitis (same criteria as for cases) recorded in the National 
Patient Register since 1970. For each patient with incident diverticulitis, up ten individuals 
were randomly selected from the Register of the Total Population and assigned the same 
index date, with matching for sex and age at the date of corresponding diverticulitis 
admission.  
Covariates included were education level, civil status and comorbidity. Information about 
education level and civil status, was obtained from the Total Registry of Educational 
Participation and the Register of the Total Population, respectively. Information about 
comorbidity was obtained from the National Patient Register and the Swedish Cancer 
Registry. Please refer to Appendix Table A6 for comorbidity disease groups and codes.  
The event of interest in this study was death, registered in the Register of the Total 
Population, throughout the study period. 
3.3 STATISTICAL ANALYSES 
3.3.1 Paper I -Association to colon cancer 
The risk of preceding admission for diverticular disease in cases (colon cancer patients) 
was estimated by odds ratios with corresponding 95% confidence intervals. Colon cancer 
mortality and overall mortality were compared in cases with and without a preceding 
admission for diverticular disease, using Cox regression and presented as hazard ratios 
with 95% confidence intervals. Calculation were made with the statistical software SAS 9.2 
(SAS institute, Inc, Cary, NC, USA). 
3.3.2 Paper II -Heritability 
Prevalence of diverticular disease was calculated as the percentage of individual twins that 
were hospitalized in the entire twin cohort as well as within zygosity.  
Probandwise concordance was defined as 2 x hospitalized concordant pairs / (2 x 
hospitalized concordant pairs + discordant pairs. This was calculated for all zygosity 
groups and is a measure of the probability of one twin to have been hospitalized with the 
disease given that the co-twin has been hospitalized (258).  
Co-twin odds-ratio (OR) was estimated for monozygotic and same-sex dizygotic twins. 
This is a measure of relative increase in odds of hospitalization of diverticular disease for 
one twin given the presence/absence of hospitalization in the co-twin. 
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Tetrachoric correlation was calculated for all zygosity classes. It is a measure to estimate 
a correlation between two dichotomized variables and is commonly used in twin studies. 
Higher tetrachoric correlation in monozygotic compared to dizygotic groups would indicate 
the presence of genetic effects (259). These calculations were made with the statistical 
software SAS 9.2 (SAS institute, Inc, Cary, NC, USA). 
Mx, a software package designed for structural equation modeling used in twin studies, was 
used to estimate the relative importance of shared genetic effects (A), shared 
environmental effects (C) and non-shared, individual specific environmental effects (E) for 
the development of diverticular disease. First, we fitted all components (ACE) in the model 
estimating those proportions, and then tested if we could omit the C component in the 
model without reduction of model fit (260, 261). 
3.3.3 Paper III -Incidence and lifetime risk 
Statistics on population size and mortality during 1987-2010, stratified by sex, attained 
age, and calendar year, was retrieved from the Register of Total Population. For the 
calculation of admission rates, the mid-year population (calculated as the mean of the 
population at the beginning and end of the calendar year) in each stratum was used as the 
denominator. Similarly, the number of population person-time in each age/sex stratum per 
calendar year was approximated to the mean of populations in the beginning and the end of 
the calendar year (262). For the estimation of incidence rates and lifetime risk, person-
time of individuals no longer at risk of an incident event was calculated for each 
age/sex/calendar-year stratum, using individual dates of birth admission and death, 
respectively, and subtracted from the total population person-time to yield an estimate of 
person-time at risk in each stratum. 
3.3.3.1 Lifetime risks 
In order to use relatively current information, we used data from the period 2000-2010 for 
lifetime risk analyses. Lifetime risk for the two events of interest were estimated using 
cumulative incidence functions based on Poisson regression models, treating death as a 
competing event (38). 
3.3.4 Paper IV -Mortality 
The cohort was followed until the first in order of these events: 
• event of death 
• migration 
• first time admission with diverticulitis in corresponding disease-free individuals 
• end of study period  
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In the last three events above, the individual became censored. Individuals in the disease-
free cohort were moved to the diverticulitis cohort at date of admission for diverticulitis, if 
this occurred, and from that date no longer included in the disease-free cohort. 
For comparison over time, the study period was divided into two calendar time intervals, 
years 1990-1999 and 2000-2010. 
Cumulative mortality was calculated as Kaplan-Meier 1-survival estimates for the whole 
study period. Cumulative death proportions at 100 days and five years of follow-up were 
noted. Information about in-hospital mortality and hospital length of stay at diverticulitis 
hospitalization was also registered. 
Cox regression models stratified on the matched sets were used to calculate hazard ratios 
(HR). Adjustments were made for education level, civil status, year of diagnosis, and 
comorbidity. Separate analyses were performed after stratification for sex, age group (30-
49, 50-69, ≥70 years), calendar time period (1990-1999, 2000-2010) and whether 
diverticulitis patients were treated by surgery or conservatively. Follow-up time was 
divided into i) day 0 to day 100 (for short term mortality) and ii) day 101 to 5 years (for 
long term mortality) after index date. This time band was used as an interaction term with 
exposure, which allowed for different hazard ratios in the different time periods. 
Attributable risk percentage (ARP) was calculated from Cox regression. All statistical 
analyses were performed with Stata SE, version 14.2 (Stata Corp, College Station, TX, 
USA)  
3.4 ETHICAL ASPECTS 
Permission to compile and to publish these data was obtained from the Stockholm regional 
research ethics review board (dnr 2007/1335-31/4, 2010/322-31/2, 2010/1111-31/2, 
2010/1114-32, 2011/1317-32). Data have been managed according to the Karolinska 
Institutet regulations for keeping and analyzing research information. Data was anonymized 
by Swedish National Board of Health and Welfare and Statistics Sweden before delivered to 
us. The code keys for linking data to persons has been kept at Swedish National Board of 
Health and Welfare and Statistics Sweden. 
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4 RESULTS 
Below are summaries of results. For the complete results, please see the appended papers. 
4.1.1 Paper I -Association to colon cancer 
The first year before a diagnosis of colon cancer, the proportion of patients that was 
hospitalized for diverticular disease was significantly higher among cases than controls. 
Odds ratios were highest the first six months (up to 31.49 [95% CI 19.00-52.21]), 
independent of calendar time period. After the first year there was no general pattern of 
increased risk (Table 8). 
Table 8. Odds ratios (OR) by time intervals from preceding admission for diverticular disease to 
diagnosis of colon cancer in cases (N=41 037) and controls (N=82 074) during three time periods in 
Sweden, 1992-2006 
 Cases 
n, (%)  
Controls 
n, (%) 
OR (95% CI) 
1992–1996 
1997–2001 2002–2006 
No  
diverticular 
disease 
39,705 
(96.8) 
80,929 
(98.6) 
Reference Reference Reference 
Diverticular 
disease 
before colon 
cancer 
(months) 
     
0–6 760 
(1.9) 
59 (0.1) 22.75 (14.06–
36.82) 
31.49 (19.00–52.21) 25.34 (16.72–38.39) 
7–12 64 
(0.2) 
54 (0.1) 1.67 (0.88–3.18) 2.18 (1.21–3.93) 5.33 (2.48–11.47) 
13–18 41 
(0.1) 
56 (0.1) 0.93 (0.42–2.06) 1.77 (0.90–3.46) 2.11 (1.05–4.26) 
19–24 35 
(0.1) 
54 (0.1) 1.60 (0.75–3.42) 2.14 (1.03–4.44) 0.67 (0.30–1.49) 
25+ 432 
(1.1) 
922 
(1.1) 
0.85 (0.65–1.12) 1.14 (0.94–1.38) 0.88 (0.74–1.04) 
Total 1,332 
(3.2) 
1,145 
(1.4) 
   
The number of preceding hospitalizations for diverticular disease, showed no general 
relation to colon cancer. 
Cases with left sided colon cancer were to a higher extent associated with previously 
hospitalization with diverticular disease than those with a right sided colon cancer, 
especially the first year but the confidence intervals coincide and were wide. The later 
time period the risk was higher for both sides. There was no general pattern of increased 
risk after one year, similarly to the findings in the all-colon analysis described above. 
Cumulative mortality for death in colon cancer and overall death was similar in colon 
cancer cases with or without preceding hospitalization for diverticular disease. Cox 
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regression analyses did not show increased hazard ratios for death in colon cancer or all 
death causes in cases with preceding hospitalization for diverticular disease. 
4.1.2 Paper II -Heredity 
We identified 104,452 twins in the Swedish Twin Registry, after exclusions. Of these twins, 
13 994 pairs were monozygotic, 20 073 pairs were same-sex dizygotic and 18,159 pairs 
were opposite sex-dizygotic. Of the monozygotic twins, 46% were of male sex and of the 
dizygotic-same sex, 47%. 
In all, 2,296 (38% males) twins had been hospitalized with diverticular disease, as main or 
secondary diagnoses, in the National Patient Register. The prevalence for hospitalization 
for diverticular disease was 2.2%; monozygotic twins 2.0%, same-sex dizygotic twins 2.3% 
and opposite sex-dizygotic 2.2%. Distribution of zygosity in concordant and discordant 
twin pairs is presented in Table 9. 
Table 9. Twin similarity and correlations of liability for diverticular disease (both primary and 
secondary diagnoses) 
Zygosity Concordant 
pairs with 
no DD* 
Concordant 
pairs with 
DD* 
Discordant 
pairs with 
DD* 
Probandwise 
concordance 
Tetrachoric 
correlation (95% 
CI**) 
Monozygotic Total 13,479 31 484 0.11 0.39 (0.30-0.47) 
Male 6,177 11 188 0.11 0.39 (0.25-0.53) 
Female 7,302 20 296 0.12 0.38 (0.27-0.49) 
Dizygotic Total 36,536 54 1,642 0.06 0.21 (0.15-0.27) 
Male 9,058 10 317 0.06 0.23 (0.10-0.37) 
Female 10,107 22 559 0.07 0.21 (0.11-0.31) 
Same sex 19,165 32 876 0.07 0.22 (0.15-0.30) 
*DD=Diverticular disease **CI=Confidence Interval 
When including both main and secondary diagnoses in analyses, we found higher 
probandwise concordance rates and tetrachoric correlations for monozygotic compared to 
corresponding dizygotic pairs (Table 9). The co-twin OR was 7.15 (95% CI: 4.82–10.61) 
for monozygotic twins compared to 3.20 (95% CI: 2.21–4.63) for same sex-dizygotic twins.  
When including only twins with primary diagnoses, 1902 (37% males) twins were registered 
with hospitalizations for diverticular disease. Probandwise concordance and tetrachoric 
correlations, did not differ substantially from the combined primary and secondary 
diagnoses. 
The results of structural equation model fitting to our data of both main and secondary 
diagnoses of diverticular disease are shown in Table 10. Since tetrachoric correlations 
were similar between sexes, the results are shown for sexes combined for monozygotic and 
dizygotic twins. In the model where A, C and E was included, the C parameter was not 
significantly different from 0. Therefore, we could omit the C parameter without any 
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significant reduction of model fit. The proportion of the variance in liability to diverticular 
disease attributable to additive genetic effects (parameter A), was then 40%, and the non-
shared environmental influence (parameter E), 60%. When using only primary diagnoses in 
the analysis, results were similar (Table 10). 
Table 10. Estimation of genetic and environmental effects for diverticular disease 
Classification of 
diagnoses 
Model A: Genetic effects 
(95% CI*) 
C: Shared 
environmental 
effects (95% CI*) 
E: Non shared 
environmental 
effects (95% CI*) 
Primary and 
secondary 
diagnoses 
ACE  0.40 (0.18-0.47) 0.01 (0-0.15) 0.60 (0.53-0.69) 
AE (C set to 0) 0.40 (0.33-0.47) - 0.60 (0.53-0.67) 
Only primary 
diagnoses 
ACE 0.43 (0.25-0.51) 0 (0-0.12) 0.57 (0.49-0.65) 
AE (C set to 0) 0.43 (0.35-0.51) - 0.57(0.49-0.65) 
*CI=Confidence Interval 
 
4.1.3 Paper III -Incidence and lifetime risk 
We identified in total 144,107 (66% females) hospitalizations for diverticular disease in 
95,049 (63 % females) individuals with a median attained age at first hospitalization of 62 
years in men and 67 years in women. There were 17,599 (60% females) hospitalizations 
with bowel resection or stoma formation with a diagnosis of diverticular disease in 16,824 
individuals (60% females). The total number of person-years in the population years 1987-
2010 was 213,949,897.  
Overall, the standardized incidence rates during the study period were 47.4 and 8.4 per 
100 000 person-years for hospitalization and surgery, respectively. The corresponding 
admission rates were 70.8 for hospitalization and 8.7 for surgery. 
Incidence rates and admission rates for both hospitalization and surgery for diverticular 
disease were higher in females. In the years 1990-1994, there was an increase of 
hospitalizations in both sexes, but years before and after they were relative stable. 
Hospitalization and surgery with diverticular disease were more common with increasing 
age. Incidence rates for hospitalization were increasing in younger age groups of men over 
the different calendar time periods but there was no consistent change of the incidence of 
surgery in any age group over time of study. 
Age-specific incidence rates of hospitalization were largely equal between sexes at ages 
30-45, followed by higher rates in women with a peak between 80 and 90 years of age. The 
incidence of diverticular disease surgery was higher in women from approximately 55 years 
of age, compared to men.   
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The estimated remaining lifetime risk at age 30 being hospitalized for diverticular disease 
was 3.1% in men and 5.0% in women. Corresponding for surgery for diverticular disease was 
0.5% and 0.8%. 
4.1.4 Paper IV -Mortality 
4.1.4.1 Cohort characteristics 
The diverticulitis cohort consisted of 83,461 (9,510 surgically and 73,951 conservatively 
treated) patients after exclusions were made. Of these, 63.2% were female. The matched 
disease-free cohort comprised 812,942 individuals. Diverticulitis patients had a higher 
comorbidity compared to individuals in the disease free-cohort.  
4.1.4.2 Cumulative mortality 
During a maximum follow-up of 21 years, diverticulitis patients and disease-free 
individuals were monitored 623,918 and 6,438,357 patient years respectively. 27,382 and 
226,007 deaths were observed, corresponding to mortality (rates) of 43.9 (95% CI 43.4-
44.4) and 35.1 (95% CI 35.0-35.2) deaths per 1000 person-years. 
The proportion of individuals who died in the first 100 days and 5 years was 4.1% (95% CI 
4.0-4.3%) and 20.3% (95% CI 20.0-20.6%) for diverticulitis patients and 0.8% (95% CI 0.7-
0.8%) and 14.5% (95% CI 14.4-14.5%) for disease-free individuals.    
The cumulative mortality in diverticulitis patients was similar when comparing sexes. At 
100 days, the death proportion was 4.1% in both males and females. At 5 years the 
proportion of men with diverticulitis who had diseased was 21.1% (95% CI 20.6-21.6%) 
compared to 14.7% (95% CI 14.6-14.9%) in disease-free individuals. Corresponding 
proportions for women were 19.8% (95% CI 19.5-20.2%) and 14.3% 95% CI 14.2-14.4%). 
Surgical treatment in diverticulitis patients was associated with an almost four times higher 
death proportion after 100 days compared to conservative treatment, 11.4% (95% CI 10.8-
12.1%) vs. 3.2% (95% CI 3.1-3.3%). In the comparison cohort, 0.8% (95% CI 0.7-0.8%) 
[conservative reference cohort] and 0.8% (95% CI 0.7-0.9%) [surgical reference cohort] 
were dead after 100 days. After 5 years, death proportion was 29.0% (95% CI 28.1-30.0%) 
in patients with initial surgical treatment, and 19.2% (95% CI 18.9-19.5%) in conservative 
treatment. This should be compared to 14.6% (95% CI 14.4-14.9%) and 14.4% (95% CI 
14.4-14.5%) of the disease-free individuals, respectively. 
Mortality during the hospital stay decreased slightly over time for conservative treatment, 
from 0.92% during years 1990-1999, to 0.79% 2000-2010, but increased for surgical 
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treatment, from 6.27% to 6.73%. The average hospital length of stay decreased over the 
two calendar periods, with about one day for both treatment groups. 
4.1.4.3 Mortality from regression models 
The diverticulitis cohort had over 4 times increased hazard rates for death the first 100 
days after initial admission (HR 4.44 [95% CI 4.26-4.63]), compared to disease-free 
individuals. From day 101 to 5 years, hazard rates were increased by 11% (HR 1.11 [95% 
CI 1.09-1.13]).  
Surgical treatment was associated with the highest hazard ratios, both in short term, HR 
12.13 (95% CI 11.03-13.34) and long term, HR 1.40 (95% CI 1.32-1.47). 
The first 100 days, the relative increase in hazard rates was slightly higher in female 
patients, HR 4.75 (95% CI 4.51-5.01), than in males, HR 3.99 (95% CI 3.72-4.27). Long 
term hazard ratios were similar between sexes. There was no apparent pattern of 
advancing age affecting hazard ratios. 
The later calendar period (2000-2010) was associated with slightly higher hazard ratios 
compared to earlier calendar period (1990-2000) in the short term but they were similar in 
the long term.  
The adjusted overall attributable risk percentage for diverticulitis was 77,5% the first 100 
days and thereafter up to five years 9.8%. Corresponding figures for surgically managed 
hospitalization was 91.8% and 28.4% and for conservative 70.9% and 7.0% 
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5 DISCUSSION 
5.1.1 Association to colon cancer 
Four possible types of theoretical relationships between the diverticular disease and colon 
cancer have been described: 1) Both diseases are associated due to causal relationships 2) 
Both diseases are associated due to common risk factors and similar causes 3) Both 
diseases are separate entities and are unrelated 4) Separate diseases but somehow related 
(eg. one may cause diagnostic problems of the other) (263). Chronic inflammation, 
alterations in the extracellular matrix, dysregulated cell proliferation and dysbiosis in 
diverticular disease patients, promoting carcinogenesis, have been speculated as possible 
links between the disorders (263). 
Our study (Paper I) of all registered colon cancer patients in Sweden during 1992-2006 
showed an increased risk of colon cancer within the first year, and particularly the first 6 
months, after hospitalization for diverticular disease. No association between 
hospitalization for diverticular disease and colon cancer was found thereafter. 
The first-year association with colon cancer in our study was probably mainly caused by 
misclassification and surveillance bias. Since the two disorders can present with similar 
symptoms and it sometimes is difficult to distinguish clinical and radiological findings, a 
colon cancer can be misclassified as diverticulitis, where after a subsequent colon 
examination reveals the cancer (45, 264-266). Follow-up colonoscopy is recommended 
within the first two months after a first-time diverticulitis episode but in Sweden the 
waiting time might well exceed 6 months for patients with a stable clinical condition. 
Surveillance bias can be present as patients with diverticular disease might have symptoms 
leading to colon examination in a greater extent than diverticular disease-free individuals. 
There might be controls with unknown colon cancer that would be found if they were had 
their colon examined in the same extent as cases. 
Our conclusion is that diverticular disease does not increase the risk of colon cancer per 
se, but that colon cancer should be excluded after a first hospitalization. 
Most studies on the issue published before 1993, including cross-sectional studies of 
endoscopic findings did not find any association between diverticular disease and colon 
cancer except from Morini et al, who found a positive association between diverticulosis 
and colon ademonas in a case-control study (55). In 1993, Stefansson et al found an 
association between diverticular disease and the risk of colon cancer with a relative risk of 
1.8 (95% CI 1.1-2.7) in all age groups and both in males and females in a Swedish register-
based cohort study, including 7,159 patients hospitalized in Uppsala health care region for 
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diverticular disease, during the years 1963-1983. The increased risk of colon cancer was 
found to be only in left colon. Based on these results, many medical centres started 
surveillance programs for diverticular disease patients. In 2004, the same authors did a 
nested case-control follow-up study and hypothesized that it could be the inflammation in 
diverticulitis that was the driving force to formation to malignancy. An OR of 4.2 (95% CI 
1.3-13.0) for developing colon cancer was found for diverticulitis patients compared to 
diverticulosis patients. However, these two studies of great impact included patients at a 
time when diverticulitis patients mainly were diagnosed by barium enema or solely clinically 
without radiological examination. In our study of patients hospitalized during 1992–2006, 
CT was most likely, widely used to enhance diagnostic accuracy, with sensitivity of 93–98% 
and specificity of 75–100% (213). Other later studies, including cross-sectional endoscopic 
findings and case-control studies in which colon cancer patients are compared to a colon 
cancer free group and incidence of diverticulosis is examined in surgical specimen or by 
endoscopic or radiological findings, have in some extent been contradictory (Table 6). In a 
review article from 2008, Morini described that studies so far had several limitations and 
that there was not enough evidence yet to recommend surveillance programs (44). After 
our study, another large register-based study was performed in Taiwan, including 41,359 
patients. In this cohort study with a disease-free comparison group, diverticular disease 
patients were classified as having diverticulosis or diverticulitis. Results were similar to 
ours. The first year after diagnose the risk for colorectal cancer was increased (HR 4.54, 
95 CI 4.19-4.91) but when excluding the first 12 months there was no increased risk for 
colorectal cancer, neither in diverticulosis nor diverticulitis group (65). They also 
concluded that diverticular disease is not associated with colon cancer after one year. This 
strengthens the fourth of the above-mentioned hypotheses, that diverticular disease and 
colon cancer are separate diseases but related in diagnosing. Regarding colonoscopy after 
initial hospitalization for diverticulitis, there is still an ongoing debate. Daniels et al 
compared findings of advanced colonic neoplasia at follow-up colonoscopy in patients with 
CT-proven uncomplicated diverticulitis to those in participants in a primary colonoscopy 
colorectal cancer screening program and found no significant differences in the groups 
(267). Updated guidelines internationally are still recommending routine follow-up 
colonoscopy after first episode of diverticulitis (267). Perhaps it will be possible in the 
future to differentiate the group of diverticulitis patients to those with lower and higher 
risk of colon cancer findings after a diverticulitis episode respectively, and to exclusively 
re-examine the colon on those who have the benefits of this extra investigation. This 
approach would need further research, preferably in prospective settings. 
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5.1.2 Heredity 
Our twin study on diverticular disease patients we found that genetics contributes to 
disease occurrence. The results were similar when analyzing both primary and secondary 
diagnoses compared to analyzing primary diagnoses alone. This might indicate that 
inflammation in diverticulitis (which is considered predominant in primary diagnoses) does 
not differ in genetic susceptibility to that of diverticulosis (please see "5.2 Methodological 
considerations " for further discussion on this topic). The twin study model relies on some 
assumptions including equal environmental influences for monozygotic and dizygotic twins, 
random mating and no interaction between genes and environment. These assumptions 
might lead to an over- or underestimate of the genetic component. Lifestyle factors or use 
of drugs that are known to influence the risk of diverticular disease could differ in different 
zygosity groups and could influence the results, although this is unknown. The relative 
influence of genetic and environmental factors could also differ in different populations; 
therefore, the results might not be generalizable to all parts of the world. 
One year after our study, Strate et al published a similar twin study from the Danish Twin 
Registry, including also outpatients in the latter part of the study period. In addition, they 
analyzed incidence of diverticular disease in siblings of a diverticular disease case 
compared to the incidence in the general population (standardized incidence ratios, SIR). 
Their twin study results resembled ours, with an estimated genetic susceptibility for 
diverticular disease occurrence of 53% (95% CI 45-61%). Their analyses of siblings revealed 
a relative risk for diverticular disease in siblings of diverticular disease patients of 2.92 
(95% CI 2.50-3.39) compared to the general population. This strengthens our conclusion 
of the importance of a genetic factor. The pathophysiological pathways of genetic influence 
on diverticular disease have been suggested to include connective tissue alterations, 
neuromuscular abnormalities and differences in mucosal immunity, but is still unknown. 
(162). 
5.1.3 Incidence and lifetime risk 
Our nation-wide cohort study of admission rates, incidence rates and lifetime risk of 
hospitalization and surgery of diverticular disease, included 95,049 individuals, with 
144,107 admissions. We found an increase of admission rates and incidence rates of 
hospitalization for diverticular disease during the first years of 1990's, but thereafter the 
rates were relatively constant. However, the rates of diverticular disease surgery remained 
essentially unchanged throughout the study period. We estimated that approximately one 
in 33 men and one in 20 women are likely to be hospitalized with diverticular disease 
during their lifetime, which corresponds to about six times their risk for diverticular 
disease surgery.  
  43 
The observed increase of hospitalization with diverticular disease in the beginning of the 
study period is probably not reflecting an increase in the true incidence but might be 
related to other aspects as improved diagnostics (such as computed tomography becoming 
more frequent used (268)) or changes in coding practices. Before 1987, some hospitals in 
Sweden were not yet registering hospitalizations in the National Patient Register (see 3.1.2 
National Patient Register) and therefor some cases in the beginning of the study period 
might not be incident. However, these false incident cases should then probably have 
occurred already in 1987. 
In United States, increased admission rates, in the time period 1998-2001, have been 
found, which was not evident in our material of Swedish patients. However, admission rates 
were similar to ours in the time period 2002-2005 (35, 33). Admission rates in Sweden 
were noticeably lower than those reported from Ontario, Canada (40). Two English studies 
on admission rates, using somewhat different selection criteria than ours, have been 
published. Kang et al found lower admission rates than in Sweden between 1989/1990 and 
1999/2000 and Jeyrajah et al revealed admission rates surpassing the Swedish ones 
between 1996 and 2006, probably largely due to an increase of included daycases (34, 41). 
In Levanger, Norway, both admission rates and incidence rates 1988-2012 were reported 
lower than ours, partly due to stricter selection criteria (43). Incidence rates including 
both hospitalizations and outpatient visits, in Olmsted County, Minnesota, were 
considerably higher than ours (36).  
Differences in reported admission rates and incidence rates can result from somewhat 
different definitions of events. We have strived to use event definitions that would 
minimize the extent of misclassification but cannot distinguish the different sub-
classifications. Also, our study is nation-wide covering all defined events in the population 
during the study period which is not the case with several of the other reports. 
Some previous studies have reported an increased incidence of diverticular disease, most 
pronounced in the young (33, 35, 36). Our report presents a consistent increase only in 
the group of young men.  
Our study is the first to investigate lifetime risk of diverticular disease. The estimates are 
dependent on incidence rates (which are dependent on the event definition used and the 
extent of misclassification), as well as the impact of mortality. We did only include 
hospitalizations for diverticular disease and since the disorder can also be managed in an 
outpatient setting, the overall risk of being treated for diverticular disease is probably 
higher. The expected future increase in lifetime will presumably lead to higher proportions 
of individuals developing symptomatic diverticular disease in their lifetime and possibly 
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even higher proportions needing hospital care (274). This scenario might add to the 
burden that diverticular disease poses on our health care systems. 
5.1.4 Mortality 
In our nation-wide cohort study of mortality in 83.461 hospitalized diverticulitis patients 
we found a 4 times increased mortality within the first 100 days and 11% increased 
mortality thereafter up to five years, compared to matched disease-free individuals. 
Surgical patients had 12 times respectively 40% increased mortality. Diverticulitis could 
thereby be regarded as a quite deadly disease, particularly when surgery is needed. 
According to our results, death occur frequently up to several months after surgery. The 
Accordion Severity Grading System of surgical complications has lately recommended 
extending the general time period for postoperative deaths from the more common used 30 
days to 100 days (269). Edna et al. found a death proportion at 7.5% 100 days after initial 
hospitalization of in a mix of 650 conservative and surgically treated patients with acute 
diverticulitis, in Levanger, Norway, which is higher than our proportion of 4.1%. They 
found an all in-hospital death proportion of 6.1%, compared to ours of 0.79-0.92% in 
conservative treated and 6.27%-6.73% in surgically treated patients. In their study 12.3% 
had surgical treatment compared to 11.4% in our study (270).  
Studies of long-term mortality in diverticulitis, for comparison, are rare. 5-year death 
proportion has been reported to be 14.1% after discharge from initial conservative managed 
admissions (72). In our study, the 5-year death proportion of 19.2% in these patients also 
include deaths in-hospital. Humes et al. have investigated long-term mortality of 953 
diverticulitis patients with perforated colon and found a HR of 5.63 (95% CI 4.68-6.77). 
Our results of a HR 1.40 (95% CI 1.32-1.47, p-value <0.001) in surgically treated 
patients, include a broader spectrum of disease severities and long-term follow up was 
defined differently, as from day 101 to 5 years after admission.  
We found that diverticulitis patients have more comorbidity than matched disease-free 
individuals, which is accounted for in the regression models. Patients being hospitalized for 
any kind of disease are probably more disposed to comorbidities than the general 
population and also for this reason have a higher mortality. Therefore, this is important 
adjusting for. 
Our study comprises the entire spectrum of disease severity in diverticulitis-patients and 
demonstrates the increased mortality in this disease-group. The results might be useful 
when comparing mortality to other disease-groups, evaluating new treatments and 
prioritizing health care resources. The individual altered risk of dying because of this 
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disease is probably mostly dependent on its severity and if surgery is needed, together 
with comorbidities and the patients’ general condition. 
5.2 METHODOLOGICAL CONSIDERATIONS  
There are several methodological aspects that are related to all four studies that need to 
be discussed further as they are potential limitations.  
Classification of diverticular disease is a limitation in our studies. Diverticular disease is a 
spectrum of conditions, from asymptomatic diverticulosis, to the presence of less severe 
symptoms without signs of overt inflammation (SUDD) to diverticulitis. Diverticular 
bleeding is in addition a common complication separated from those related to diverticulitis 
but might itself lead to hospitalization. The existence of diverticula is apparent at 
endoscopy (colonoscopy and sigmoidoscopy) and radiological examinations such as 
computed tomography, magnetic resonance imaging, barium enema x-ray and ultrasound. 
Since the prevalence of diverticulosis is high and most patients do not have symptoms 
related to the diverticulosis, findings of diverticula, en passant, at investigations aimed at 
other disorders than diverticula-related ones are common. The diagnoses in the Swedish 
health registries used in our studies are based on the World Health Organization's 
International Classification of Diseases (ICD). While the 8th version of ICD, used until 
1986, separated diverticulosis and diverticulitis, the succeeding versions 9 and 10 (used 
years 1987-1996 respectively 1997-present) do not. In version 9 there is only one 
common code for diverticulosis and diverticulitis and in version 10 one can only 
differentiate disorders with or without perforation in the colon wall and/or the existence of 
an abscess. Diverticulitis without perforation and abscess and asymptomatic diverticulosis 
or SUDD can therefore not be distinguished only by knowledge of the registered codes. 
One can however take into account if the code is registered as a primary or secondary 
code. The primary code is mainly used for the disorder that causes the symptoms or is the 
most important in the clinical setting while secondary codes many times can be considered 
as not directly causing the symptoms or as comorbidity. Asymptomatic diverticulosis, we 
believe, is therefore most commonly registered as a secondary code and diverticulitis 
registered as a primary code. The condition SUDD has most recently, after the study 
periods, gained more attention and diverticula without diverticulitis have earlier generally 
not being considered as a cause of symptoms, minimizing its portion of primary codes in 
inpatient setting. Hospitalization for a gastrointestinal bleeding caused by diverticula is 
mainly registered with both a code for gastrointestinal bleeding and a code for diverticular 
disease of which gastrointestinal bleeding is probably often the primary code, but this 
might differ in different hospitals. In the four studies, we have used somewhat different 
definitions of the disease of study. This is partly due to different approaches, as we in 
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Paper II and Paper III aimed to "catch" as many patients in the broader disease spectrum 
as possible, when studying incidence, admission rates and heritability, while it was more 
important to narrow the disease definition to solely diverticulitis patients when studying 
this patient category’s mortality, with the potential cost of missed patients (Paper IV). 
The different approaches are also a result of our effort to enhance the precision of disease 
definition over time, which can be seen in differences of definition in Study I and Study IV; 
in both studies we were most interested in patients hospitalized for diverticulitis. The 
diverticular disease diagnoses registered in the Swedish inpatient register have not yet 
been validated in a large study which is drawback. There are however some reports 
available on the issue. Rosemar et al. studied 112 men with diverticular disease registered 
as primary or secondary codes in the National Patient Register. The diagnosis was verified 
in all the 107 cases in which medical records could be retrieved. Of these, 16 were 
gastrointestinal bleeding, 5 were diverticulosis, and the rest were diverticulitis with or 
without complications (271). Erichsen et al. analyzed the version 10 of the ICD-codes of 
diverticular disease in a sample of 100 patients in the Danish National Registry of Patients 
and found a positive predictive value (PPV) for diverticular disease in general of 0.98 (95% 
CI 0.93-0.99). Combined PPV for codes including any complication (codes K572, K574, 
K578) was also satisfactory, at 0.91 (95% CI 0.71-0.99) but identification of uncomplicated 
disease was found inaccurate. This study included however also outpatients and there was 
no separation of primary and secondary diagnoses. Furthermore, in a study of Dr. F Hjern 
(parts of the results are unpublished), the medical records of 529 consecutive inpatients 
with primary ICD-10 codes K572-9, at Danderyd Hospital, Stockholm, in years 2000-
2002, were re-evaluated for validation. In all, 96% were correctly classified. Eighty-eight 
per cent had acute diverticulitis (of these, 78% of diagnoses were supported by computed 
tomography and/or surgical findings), 4% had elective surgery due to diverticulitis, 2% had 
diverticular bleeding and 3% were hospitalized for bowel preparation preceding a colon 
examination showing diverticulosis. Misclassification was found in 4% (in 1% subsequent 
colon examination showed colon cancer, and in 3% miscellaneous diagnoses were found) 
(187). In study IV, in which we aimed at including only patients with diverticulitis, patients 
with codes of gastrointestinal bleeding and those with a later diagnose of colon cancer 
were excluded, in addition only first admissions were included. These modifications of 
disease definition might have led to a higher proportion of diverticulitis patients included. 
Another shortcoming is that no strict diagnostic criteria exists for diverticulitis. The 
diagnoses in our studies are most probably based upon clinical features, together with X-
ray, or surgical findings consistent with diverticulitis. The major change in diagnosing 
diverticulitis the last decades, which probably have had an impact on proportion correct 
diagnoses, is the switch of standard radiological modality from barium enema x-ray to a 
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trans-sectional imaging by computed tomography. This change did however mainly occur 
prior to our study periods and should therefore have little effect on the results over time. 
Most international guidelines recommend trans-sectional imaging, but in some countries, 
ultrasound is used in as high degree instead of CT, which in theory might affect 
generalizability since the two methods could lead to different degrees of misclassification. 
However, both modalities are shown to have high sensitivity and specificity (236). 
Since diverticular disease can be managed by other health care options than as inpatients 
in hospitals, on which our studies are based, results cannot automatically be generalized to 
include all diverticular disease patients. As most individuals have no symptoms related to 
their diverticulosis, they will never seek health care due to this condition. In Paper II, in 
which heritability was investigated, we aimed to include as many individuals as possible in 
the diverticular disease spectrum, using both primary and secondary diagnose codes 
(primary diagnose codes were also analyzed separately) in order to also include some of 
the patients without diverticulitis. Some of these, diagnosed by secondary codes, were 
probably asymptomatic findings during an investigation for other reason while others had 
SUDD. These groups of patients are probably not completely covered in our study. 
Another group of patients, that we might have missed, is diverticulitis patients that are 
treated as outpatients or in primary care. These patients are likely to mostly have a less 
severe disease than those needing inpatient care. The majority of diverticulitis patients are 
however diagnosed with diverticula at some time, and this is done from radiological or 
endoscopic investigations, many times in an inpatient setting. Still, the patients that are 
diagnosed with diverticulosis in an outpatient examination and thereafter seek primary care 
for less severe diverticulitis symptoms without needing hospital care, are likely to be 
missed in our studies.  
In the first paper, investigating colon cancer association, these missed patients of 
asymptomatic diverticulosis, SUDD and less severe diverticulitis might not be as important 
since the main hypothesis stated inflammation as the driving force in malignant 
transformation. In Paper III, only hospitalized patients were of relevance since hospital 
incidence, admission rate and lifetime risk of hospitalization were the subjects investigated. 
If in Paper IV, one could include all diverticulitis patients with less severe disease never 
being treated in hospital, mortality would probably be lower than we reported. 
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6 CONCLUSIONS 
• Hospitalization for diverticular disease is not associated with colon cancer after one 
year. The first 12 months after initial hospitalization is however highly associated 
with colon cancer. Therefore, colon cancer should be excluded after a first episode 
of suspected diverticulitis, because the risk of misdiagnosing colon cancer as 
diverticulitis 
• Genetic influence accounts for approximately 40% of the occurence in diverticular 
disease. 
• Age standardized incidence rates for hospitalization with diverticular disease is 47 
per 100 000 person-years and 8 for diverticular disease surgery. The 
corresponding admission rates are 71 och 9. The continous increase of diverticular 
disease hospitalizations found in other studies is not present in Sweden. The 
remaining lifetime risk for hospitalization at 30 years of age is 3% in men and 5% in 
women. 
• Diverticulitis patients have a significantly reduced survival compared to disease-
free individuals, both in short- and long-term. The first 100 days after initial 
admission, patients have a four times higher mortality than diverticulitis-free 
individuals. 11% of patients undergoing surgery and 3 % of the conservatively 
treated patients die during this time period. From day 101 to 5 years surgical 
treatment is associated with 40% increased mortality and conservative treatment 
8%. 
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7 FUTURE RESEARCH 
Ten-fifteen years ago, little was known about diverticular disease, despite its great impact 
on the Western world public health care systems. Much of the knowledge was based on 
studies from the 1970's. However, the last years, diverticular disease have gained interest 
in the research community and many earlier findings have been questioned. Therefore, in a 
way, more issues now need to be answered than ever before.  
The World Health Organizations' International Classification of Disease classification, used 
in many health care institutions over the world, has since the 1980's been an 
inconvenience when doing epidemiological research on diverticular disease, due to its' 
inability to easily differentiate the disorder's sub-classifications. Apparently, the next 
version, ICD-11, is expected to become more refined, which will likely facilitate future 
studies using administrative data. Until we have the new classifications in use and have 
gathered several years of new data, there is a need for a large validation study on the 
current diverticular disease coding system. Such a validation study would need to include 
separate and combined codes, primary and secondary diagnoses.  
Furthermore, we found that genetic influences are of importance in disease occurrence, 
but the pathophysiology behind the genetic effects are not known. The findings of DNA 
sequence variants found in candidate-driven studies and the GWAS need to be adressed in 
patophysiological studies.  
We found that mortality in diverticulitis is high both when initially treated surgically and 
conservative. It would be interesting to acquire deeper knowledge on the causes of death 
and how different surgical techniques might affect mortality. 
Lastly, patients treated as outpatients in either primary care or at hospital clinics are a 
group that probably will become larger as indications for inpatient care are getting stricter, 
at least in Sweden. These patients are often overlooked in diverticular disease studies and 
should be investigated further.  
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8 SWEDISH SUMMARY FOR LAYMEN 
Avhandling för avläggande av medicine doktorsgrad vid Karolinska Institutet, Institutionen 
för medicin, Solna, 2018 
Epidemiogiska studier på divertikelsjukdom i tjocktarmen 
Divertikelsjukdom innebär förekomst av fickor (divertiklar) på tjocktarmen som kan bli 
inflammerade och orsaka problem. Tillståndet är mycket vanlig hos äldre människor, över 
hälften av de i 70-80-årsåldern drabbas. Det är betydligt vanligare i utvecklade länder och 
man tror att diet kan påverka risken att få sjukdomen. De flesta med tarmfickor får inga 
symtom men ifall de blir inflammerade (divertikulit) får man ont i buken och feber. 
Inflammationen kan spridas och leda till allvarliga komplikationer som förträngningar, 
onormala gångbildningar till andra intilliggande organ (som urinblåsa eller vagina) och till 
akut livshotande tillstånd om tjocktarmen brister. 
Avhandlingen omfattar fyra epidemiologiska studier. Epidemiologi betyder läran om 
sjukdomars utbredning, orsak och påverkan i befolkningen. Studierna är baserade på de 
svenska befolkningsregister som håller en mycket hög internationell standard. Genom att 
länka samman registren via personnummer har vi fått ut anonyma data från Socialstyrelsen 
och Statistiska Centralbyrån där patienters inläggningar på sjukhus, behandlingar, 
samsjuklighet, dödlighet, utbildningsnivå, civilstånd och eventuella detaljer kring 
tvillingskap framgår. 
I delstudie 1 undersöktes om divertikelsjukdom var kopplat till cancer i tjocktarmen. Det 
har funnits hypoteser kring att inflammation i tarmväggen hos patienter med 
divertikelsjukdom skulle kunna orsaka cancer, vilket är visat i andra inflammatoriska 
tillstånd i mag-tarmkanalen. Både divertikelsjukdom och tjocktarmscancer har blivit 
betydligt vanligare i befolkningen i västvärlden senaste årtiondena och de ökar med 
stigande ålder. Därtill tror man att liknande diet kan öka risken för båda tillstånden. 
Tidigare studier har visat olika resultat och eftersom man inte med säkerhet har kunnat 
utesluta att divertikelsjukdom kan leda till tjocktarmscancer screenar man på vissa 
sjukvårdsinrättningar patienter med divertikelsjukdom regelbundet med 
tjocktarmsundersökning. Studien gjordes genom att länka samman Patientregistret, 
Registret över totalbefolkningen och Cancerregistret. Samtliga individer som 
diagnosticerats med tjocktarmscancer i Sverige under åren 1987–2006 inkluderades i 
studien. Resultaten visade att det första året efter divertikelsjukdom fanns en hög risk för 
att diagnosticeras med tjocktarmscancer men att det därefter inte fanns någon koppling 
mellan sjukdomarna. Den ökade risken första året beror sannolikt inte på att 
divertikelsjukdom i sig leder till tjocktarmscancer utan bland annat på att 
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divertikelsjukdom i det akuta skedet är svår att skilja från tjocktarmscancer och att man 
först vid den uppföljandende kontroll upptäcker cancern. Vår rekommendation blev att 
tarmen bör kontrolleras efter ett förstagångsinsjuknande i divertikelsjukdom för att utesluta 
tjocktarmscancer. 
I delstudie 2 undersökte vi om det fanns en ärftlighet i utvecklandet av divertikelsjukdom. 
Detta hade hittills varit okänd och outforskat. Svenska tvillingregistret på Karolinska 
Institutet är världens största tvillingregister och innehåller information om tvillingar sedan 
1800-talet. Detta register samt Patientregistret användes i denna studie. Genom att 
undersöka om enäggstvillingspar i högre utsträckning än tvåäggstvillingspar drabbades av 
divertikelsjukdom kunde vi förstå om det fanns en ärftlig komponent. Detta då 
enäggstvillingpar har samma genetiska material medan tvåäggstvillingpar i genomsnitt har 
till hälften samma. Resultaten visade att det finns en betydande ärftlig komponent i 
utvecklandet av sjukdomen. 
I delstudie 3 undersökte vi i vilken utsträckning individer läggs in på sjukhus för sin 
divertikelsjukdom samt hur vanligt det är med operation för divertikelsjukdom och om 
dessa saker har förändrats senaste årtiondena. Tidigare studier har visat olika resultat och 
det har saknats en studie som innefattar en hel befolkning. Vi använde oss i huvudsak av 
Patientregistret och Registret över totalbefolkningen i denna studie. I resultaten framkom 
förutom mått på ovanstående även att en frisk kvinna som är 30 år gammal har 5% risk att 
någon gång under sin förväntade kvarstående levnadstid läggas in på sjukhus för 
divertikelsjukdom. Motsvarande för män är 3%.  
I delstudie 4 önskade vi undersöka hur dödlig inflammation i tarmfickor är jämfört med en 
kontrollgrupp. För denna studie användes Patientregistret, Registret över 
totalbefolkningen, Utbildningsregistret och Cancerregistret. Resultaten visade att 
opererade patienter har en 12 gånger ökad dödlighet första 100 dagarna och därefter 40% 
ökad dödlighet upp till 5 år efter första inläggningen på sjukhus. Under de första 100 
dagarna dör över var tionde opererade patient. De patienter som har en mindre allvarlig 
sjukdom och inte behöver opereras har inte lika hög dödlighet men den är förhöjd jämfört 
med den i den friska befolkningen även efter lång tid.  
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11 APPENDIX 
Table A1. The European Association of Endoscopic Surgeons classification 
Symptomatic uncomplicated disease 
Recurrent symptomatic disease 
Complicated disease 
(Hemorrhage, Abscess, Phlegmon, Fistula, Perforation, Stricture, Purulent and fecal peritonitis, Small 
bowel obstruction due to post-inflammatory adhesion) 
Table A2. Hansen/Stock and Siewert classifications 
Hansen/Stock Siewert et al. 
0 Diverticulosis   
I Acute uncomplicated diverticulitis   
II Acute complicated diverticulitis   
 a Phlegmon, peridiverticulitis I Pericolic abscess or phlegmon 
 b Abscess, sealed perforation II Pelvic, intraabdominal, or 
retroperitoneal abscess 
 c Free perforation III Free perforation 
III Chronic recurrent diverticulitis   
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Table A3. Klarenbeek classification 
Classifi- 
cation 
Clinical presentation Imaging Treatment  
A Uncomplicated disease CT scan or US Conservative treatment 
 -Pain in left lower quadrant -Phlegmon Treatment acute episode 
 -Fever -Small abscess in 
bowel wall 
-Antibioticsa 
 -Changes in relief pattern Colonoscopy -Low residue dieta 
  -Diverticulosis Prevention 
  -Inflammation -Fibers 
   -Prevention of obesity 
   -Treatment of comorbidity 
   -Mesalazinea 
B Chronic complicated 
disease 
CT scan Elective Intervention 
  -Stenosis Sigmoid resection with primary 
anastomosis 
  -Fistula -Open 
  Colonoscopy -Laparoscopically 
  -Stenosis  
  -Fistula  
  -Blood in diverticula  
C Acute complicated 
disease 
 Acute intervention 
    1 -Fever CT scan Percutaneous drainage 
 -Painful mass -Large abscesses 
(<5cm) 
 
    2 Ileus CT scan Sigmoid resection with primary 
anastomosis 
    3 Massive rectal blood loss -Intestinal obstruction Hartmann's procedure 
  CT angio Sigmoid resection with primary 
anastomosis 
  -Contrast blush -Open 
  Colonoscopy -Laparoscopically 
  -Active diverticular 
bleeding 
Endoscopic interventiona 
   Endovascular coilinga 
    4 Generalized peritonitis CT scan Diagnostic laparotomy/laparoscopy 
  -Pneumoperitoneum -Resection with primary 
anastomosis 
  -Extraluminal contrast Hartmann's procedure 
  -Free fluid Lavage and drainagea 
aExperimental or non-evidence-based treatment 
 
Table A4. Paper II -Excluded diagnostic codes from the National Inpatient Registry 
Disease ICD 8 ICD 9 ICD 10 
Non-infectious 
colitis 
561.00-04, 561,08-09, 
563,00, 563,10, 563,98-
99, 564,10, 569,02 
555B, 555C, 555X, 556-
558 
K50.0-1, K50.8-9, K51.0, 
K51.2-4, K51.8-9, K55.0-1, 
K55.9, K52.0-3, K52.8-9 
Celiac disease 269,00, 269,98 579A K90.0 
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Table A5. Paper III and IV - Diagnose and procedure codes 
Diverticular disease of the colon 
ICD-8 562,10 Diverticulosis of the colon 
 562,11 Diverticulitis of the colon  562,18 Diverticulosis and diverticulitis of the intestine, other 
 562,19 Diverticulosis and diverticulitis of the intestine, unspecified 
ICD-9 562B Diverticulitis and diverticulosis of the colon 
ICD-10 K57.2 Diverticular disease of large intestine with perforation and abscess  K57.3 Diverticular disease of large intestine without perforation or abscess 
 K57.4 Diverticular disease of both small and large intestine with perforation 
and abscess  K57.5 Diverticular disease of both small and large intestine without 
perforation or abscess  K57.8 Diverticular disease of intestine, part unspecified, with perforation and 
abscess  K57.9 Diverticular disease of intestine, part unspecified, without perforation 
or abscess 
Peritonitis, abscess, fistula 
ICD-8 567,00 Pelvic abscess 
 567,01 Subphrenic abscess  567,02 Retroperitoneal abscess 
 567,03 Localized peritonitis 
 567,04  Diffuse peritonitis  567,08 Peritonitis, other 
 567,09 Peritonitis, unspecified  569,00 Intestinal abscess 
 569,01 Intestinal perforation 
ICD-9 567C Other suppurative peritonitis  567X Peritonitis, unspecified 
 569F Abscess of intestine  596B Intestinovesical fistula 
 619B Digestive - genital tract fistulae, female 
ICD-10 K65.0 Acute peritonitis 
 K65.9 Peritonitis, unspecified 
 K63.2 Fistula of intestine  N32.1 Vesicointestinal fistula 
 N82.3 Fistula of vagina to large intestine  N82.4  Other female intestinal-genital tract fistulae 
 K63.0 Abscess of intestine 
Colorectal cancer 
ICD-7 153 Malignant neoplasm of colon 
 154 Malignant neoplasm of rectum 
ICD-8 153 Malignant neoplasm of colon 
 154,01 Malignant neoplasm of rectosigmoid junction  154,11 Malignant neoplasm of rectum 
ICD-9 153 Malignant neoplasm of colon 
 154A Malignant neoplasm of rectosigmoid junction  154B Malignant neoplasm of rectum 
 154W Malignant neoplasm of rectum, rectosigmoid junction and anus, other 
 72 
ICD-10 C18 Malignant neoplasm of colon 
 C19 Malignant neoplasm of rectosigmoid junction  C20 Malignant neoplasm of rectum 
Inflammatory bowel disease 
ICD-8 563,00 Regional enteritis (including Crohn's disease)  563,10 Ulcerative colitis 
 563,98 Chronic enteritis and ulcerative colitis, other  563,99 Chronic enteritis and ulcerative colitis, unspecified 
 569,02 Ulcerative proctitis 
ICD-9 555 Regional enteritis (including Crohn's disease)  556 Idiopathic proctocolitis (including ulcerative colitis) 
ICD-10 K50 Crohn's disease  K51 Ulcerative colitis 
Appendicitis 
ICD-8 540 Appendicitis acuta 
 541 Appendicitis NUD 
 542 Appendicitis alia 
ICD-9 540 Acute appendicitis 
 541 Appendicitis, unqualified  542 Other appendicitis 
ICD-10 K35 Acute appendicitis 
Vascular insufficiency of intestine 
ICD-8 444,20 Mesenteric thrombosis and embolism 
ICD-9 557 Vascular insufficiency of intestine 
ICD-10 K55 Vascular disorders of intestine 
Lower gastrointestinal bleeding 
ICD-9 569D Haemorrhage of rectum and anus 
 578X Haemorrhage of gastrointestinal tract, unspecified 
ICD-10 K62.5 Haemorrhage of anus and rectum  K92.2 Gastrointestinal haemorrhage, unspecified 
Colorectal resection 
Procedure 
codes -1996 
4640 Left hemicolectomy 
 4641 Right hemicolectomy 
 4642 Ileocaecal resection  4643 Resection of transverse colon 
 4644 Resection of sigmoid colon 
 4648 Ileocolic resection  4649 Other colonic resection 
 4713 Hartmann's procedure  4651 Colectomy with ileostomy 
Procedure 
codes 1997- 
JFB20 Ileocaecal resection 
 JFB21 Laparoscopic ileocaecal resection  JFB30 Right hemicolectomy 
 JFB31 Laparoscopic right hemicolectomy 
 JFB33 Other resection comprising small intestine and colon 
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 JFB34 Other laparoscopic resection comprising small intestine and colon 
 JFB40 Resection of transverse colon  JFB41 Laparoscopic resection of transverse colon 
 JFB43 Left hemicolectomy 
 JFB44 Laparoscopic left hemicolectomy  JFB46 Resection of sigmoid colon 
 JFB47 Laparoscopic resection of sigmoid colon  JFB50 Other resection of colon 
 JFB51 Other laparoscopic resection of colon 
 JFB53 Resection of sigmoid colon with partial proctectomy  JFB54 Laparoscopic resection of sigmoid colon with partial proctectomy 
 JFB60 Resection of sigmoid colon with end colostomy  JFB61 Laparoscopic resection of sigmoid colon with end colostomy and 
closure of distal stump  JFB63 Other resection of colon with proximal colostomy and closure of distal 
stump  JFB64 Other laparoscopic resection of colon with proximal colostomy and 
closure of distal stump  JFB96 Other partial excision of intestine 
 JFB97 Other laparoscopic partial excision of intestine  JFH10 Total colectomy and ileostomy 
 JGB00 Partial proctectomy and colorectal or coloanal anastomosis  JGB01 Laparoscopic partial proctectomy and colorectal or coloanal 
anastomosis  JGB03 Partial proctectomy with partial excision of mesorectum 
 JGB04 Laparoscopic partial proctectomy with partial excision of mesorectum  JGB10 Partial proctectomy and end colostomy 
 JGB11 Laparoscopic partial proctectomy and end colostomy 
Stoma formation 
Procedure 
codes -1996 
4700 Ileostomy 
 4710 Sigmoidostomy 
 4711 Transversostomy 
Procedure 
codes 1997- 
JFF10 Loop enterostomy 
 JFF11 Laparoscopic loop enterostomy 
 JFF23 Transversostomy  JFF24 Laparoscopic transversostomy 
 JFF26 Sigmoidostomy 
 JFF27 Laparoscopic sigmoidostomy  JFF30 Other colostomy 
 JFF31 Other laparoscopic colostomy 
Endoscopic procedures 
Procedure 
codes -1996 
4674 Sigmoidoscopy with polypectomy 
 4674 Colonoscopy with polypectomy  4685 Sigmoidoscopy with biopsy 
 4688 Ileoscopy with biopsy 
 4689 Colonoscopy with biopsy  9011 Colonoscopy 
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 9012 Sigmoidoscopy 
 9023 Ileoscopy 
Procedure 
codes 1997- 
UJF32 Colonoscopy 
 UJF35 Colonoscopy with biopsy 
 UJF42 Flexible sigmoidoscopy 
 UJF45 Flexible sigmoidoscopy with biopsy  JFA15 Endoscopic polypectomy in colon 
 
Table A6. Paper IV -Comorbidity classification 
Diagnose ICD 8  ICD 9 ICD 10 
Myocardial infarction 410 410, 412 I21, I22, I25.2  
Congestive heart failure 427,00, 427,10, 
428,99, 782,40 
398X, 402, 404, 
425E-X, 428 
I09.9, I11.0, I13.0, I13.2, 
I25.5, I42.0, I42.5–I42.9, I43, 
I50 
Peripheral vascular 
disease 
440-445 093A, 437D, 440, 
441, 443B-X, 447B, 
557B-X, V43E 
I70, I71, I73.1, I73.8, I73.9, 
I77.1, I79.0, I79.2, K55.1, 
K55.8, K55.9, Z95.8, Z95.9 
Cerebrovascular disease  430-438 362D, 430–438  G45, G46, H34.0, I60–I69 
Dementia  290 290, 294B, 331C F00–F03, F05.1, G30, G31.1 
Chronic pulmonary 
disease  
490-493, 515-518  416W-X, 490-505, 
506E, 508B 508W  
I27.8, I27.9, J40–J47, J60–
J67, J68.4, J70.1, J70.3 
Rheumatic disease 712, 734, 446, 716 446F, 710A-E, 
714A-C, 714W, 
725.x  
M05, M06, M31.5, M32–M34, 
M35.1, M35.3, M36.0 
Liver disease  070, 571, 573, 
456,00 
070C-X, 456A-C, 
570, 571, 572C-W, 
573D/E/W/X, V42H 
B18, K70, K71.1, K71.3–
K71.5, K71.7, K72.1, K72.9, 
K73, K74, K76.0, K76.2–
K76.9, Z94.4, I85.0, I85.9, 
I86.4, I98.2 
Diabetes mellitus 250 250 E10, E11, E12, E13, E14 
Renal disease 403, 404, 580-584 403, 404, 582, 583, 
585, 586, 588A, 
V42A, V45B, V56 
I12.0, I13.1, N03.2–N03.7, 
N05.2– N05.7, N18, N19, 
N25.0, Z49.0– Z49.2, Z94.0, 
Z99.2  
Malignancy 140-209 140-208, 238G C00-C97 
Alcohol abuse 291, 571,00, 
571,01, 303 
265C, 291, 303, 
305A, 357F, 425F, 
535D, 571A-D, 980 
F10, E52, G62.1, I42.6, 
K29.2, K70.0, K70.3, K70.9, 
T51, Z50.2, Z71.4, Z72.1  
Pulmonary embolism 450 415B I26.0, I26,9 
 
